This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Family history of malignant neoplasm
Z21_FAMILY_HISTORY_MALIG_NEOPLASM
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
4485 |
4. Check minimum number of eventsNone |
4485 |
5. Include endpointsNone |
4485 |
6. Filter based on genotype QC (FinnGen only) |
4485 |
Control definitions (FinnGen only)
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z[8-9]
Similar endpoints
↥List of similar endpoints to
Family history of malignant neoplasm
based on the number of shared cases.
Similar with more cases:
- Persons with potential health hazards related to family and personal history and certain conditions influencing health status
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 4485 | 3759 | 726 |
| Unadjusted period prevalence (%) | 1.13 | 1.28 | 0.32 |
| Median age at first event (years) | 51.33 | 50.60 | 55.08 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3982
- Matched controls
- 39818
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
HA1AA
NOMESCO Finland
X-ray mammography
8.6
323.0
1092
1677
Z31.5
ICD-10 Finland
Genetic counselling
112.4
323.0
2789
813
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
9.2
323.0
1106
1590
H02AB02
ATC
dexamethasone; systemic
7.1
323.0
1134
2102
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
2232.8
323.0
423
*
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
5910.7
323.0
938
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
8.4
323.0
826
1199
PJA12
NOMESCO Finland
Sentinel node biopsy
6.9
323.0
973
1785
115
Kela drug reimbursment
Breast cancer
9.5
323.0
1284
1907
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
11954.2
323.0
2656
9
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
+∞
323.0
362
*
HAC20
NOMESCO Finland
Total mastectomy
10.7
321.6
661
726
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
8.6
308.3
727
1013
A04AA02
ATC
granisetron; systemic, transdermal
8.1
297.6
725
1060
A03FA01
ATC
metoclopramide; systemic, rectal
4.0
288.5
1499
5250
L02BA01
ATC
tamoxifen; oral
9.3
282.9
631
794
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
8.1
257.8
626
898
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
17.2
257.6
421
272
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
17.4
231.1
375
236
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
8.4
224.2
529
717
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
7.1
221.2
585
942
C50.99
ICD-10 Finland
Breast, unspecified
9.7
191.9
410
465
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
23.9
175.1
254
113
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
7.0
173.6
460
731
L02BG04
ATC
letrozole; oral
4.8
173.0
640
1527
A04AA55
ATC
palonosetron, combinations; systemic
7.1
165.7
434
677
TQW20
NOMESCO Finland
Tatoe
16.6
161.6
266
171
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
14.4
158.6
277
206
Z40.0
ICD-10 Finland
Prophylactic surgery for risk-factors related to malignant neoplasms
276.6
156.7
159
6
L03AA13
ATC
pegfilgrastim; parenteral
6.2
144.9
416
731
JN4BD
NOMESCO Finland
Extensive body CT
4.1
143.6
621
1706
HAB40
NOMESCO Finland
Wedge excision of mammary gland
5.0
141.1
498
1116
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
53.4
140.8
169
33
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
5.5
139.6
444
884
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
8.2
137.4
322
421
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
33.8
135.0
178
55
XX3DW
NOMESCO Finland
Time consuming IT work
3.8
133.5
634
1884
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.6
131.8
1182
5476
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
7.5
130.7
325
465
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
10.5
125.6
254
256
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.3
122.9
1586
8835
X76
ICPC
Malignant neoplasm breast female
9.0
122.5
271
321
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
7.9
121.9
292
394
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
6.0
121.1
357
644
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
13.4
119.8
215
169
B01AB05
ATC
enoxaparin; parenteral
2.4
117.5
1312
6761
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
4.8
117.2
422
958
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
5.9
116.7
348
636
A04AD12
ATC
aprepitant; systemic
8.0
115.3
275
368
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
10.0
112.0
233
247
C50
ICD-10 Finland
Malignant neoplasm of breast
7.9
111.3
266
357
HAC10
NOMESCO Finland
Subcutaneous mastectomy with preservation of mamilla
51.3
111.0
134
27
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
11.3
108.9
212
198
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
7.3
108.6
273
395
HAE99
NOMESCO Finland
Other reconstruction of breast
15.7
105.2
176
117
WX402
NOMESCO Finland
General anaesthesia
2.6
102.9
884
3905
L01BC06
ATC
capecitabine; oral
6.3
101.6
286
484
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
9.6
100.8
213
232
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
7.1
96.6
249
373
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
7.1
96.4
247
367
L03AA14
ATC
lipegfilgrastim; parenteral
8.0
95.7
227
300
NK6AN
NOMESCO Finland
Total body bone isotope imaging
7.6
94.7
231
319
Z80.9
ICD-10 Finland
Family history of malignant neoplasm, unspecified
457.9
90.6
90
*
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
5.6
90.0
278
527
ZZF00
NOMESCO Finland
Graft of adipose tissue
12.7
87.4
160
131
ZZR10
NOMESCO Finland
Flap of skin and muscle
15.4
87.4
147
99
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
7.0
86.1
222
332
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
85.0
1172
6465
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
6.9
84.9
222
339
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
84.1
1330
7772
WF003
NOMESCO Finland
Adjuvant radiotherapy
5.3
83.0
269
539
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
17.9
80.2
127
73
UJF32
NOMESCO Finland
Coloscopy
2.2
79.8
1036
5536
A04AA01
ATC
ondansetron; systemic, rectal
3.5
79.8
400
1215
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.6
77.8
378
1118
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
7.1
77.8
199
294
HAD60
NOMESCO Finland
Replacement of prosthetic implant in breast
29.9
75.4
102
35
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
7.7
75.3
181
244
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
13.9
74.9
131
97
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
7.9
74.5
177
234
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.0
74.0
315
831
TQB05
NOMESCO Finland
Puncture of skin of trunk
12.7
74.0
135
110
TPH07
NOMESCO Finland
Cathetrisation of artery
3.2
73.0
422
1423
L02BG06
ATC
exemestane; oral
7.6
69.6
169
231
WZC30
NOMESCO Finland
Teaching
2.5
68.3
594
2583
HA1BG
NOMESCO Finland
MRI examination of mammary gland with high intensity magnet
11.7
67.6
128
113
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
7.2
67.5
169
242
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
4.6
66.9
248
572
JN4AD
NOMESCO Finland
Body CT examination
3.6
66.8
328
975
ZX080
NOMESCO Finland
Image guided radiotherapy
6.2
63.3
178
299
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
5.2
62.6
203
406
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
60.3
1431
9422
HA1CM
NOMESCO Finland
Mammary gland extensive MRI examination with 3 Tesla magnet
21.9
59.8
88
41
HAB99
NOMESCO Finland
Other partial excision of mammary gland
4.7
59.6
212
468
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.2
59.0
239
600
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
6.6
58.9
157
246
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
4.2
58.9
237
592
ZXE20
NOMESCO Finland
More than three and less than five hours
2.4
58.6
545
2443
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
16.4
57.1
93
58
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
7.9
56.1
132
172
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
8.6
55.5
124
149
Z12.1
ICD-10 Finland
Special screening examination for neoplasm of intestinal tract
19.3
55.4
85
45
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.6
55.2
262
756
Z96.1
ICD-10 Finland
Presence of intraocular lens
6.5
55.1
148
234
B01AB10
ATC
tinzaparin; parenteral
3.0
52.3
330
1173
L02BG03
ATC
anastrozole; oral
6.3
52.1
144
237
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
6.9
52.1
134
200
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
6.7
50.7
133
204
HAD99
NOMESCO Finland
Other plastic operation on breast
10.2
49.7
100
100
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.7
47.8
1440
10007
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.6
47.1
224
647
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
7.1
46.7
117
168
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
45.8
1353
9320
Z80.5
ICD-10 Finland
Family history of malignant neoplasm of urinary tract
452.8
45.3
45
*
N63
ICD-10 Finland
Unspecified lump in breast
2.5
45.0
378
1592
XX1XN
NOMESCO Finland
Other isotope examination
8.4
44.4
100
122
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
6.4
43.2
117
188
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
15.4
42.7
71
47
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
5.5
42.4
130
244
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
3.8
42.3
185
498
QBE30
NOMESCO Finland
Excision and repair of surgical scar in trunk
10.6
42.1
83
80
L03AA02
ATC
filgrastim; parenteral
4.4
42.1
157
364
HA3AT
NOMESCO Finland
Pucture of mammary gland cyst with ultrasound examination
8.3
42.0
95
117
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
41.9
731
4243
HAD50
NOMESCO Finland
Removal of prosthetic implant from breast
12.1
41.2
76
64
R4110
NOMESCO Finland
Physiotherapy
1.7
40.9
964
6166
Z97.4
ICD-10 Finland
Presence of external hearing-aid
144.9
40.8
43
*
ZX120
NOMESCO Finland
Intravenous
2.4
40.7
371
1629
ZXE40
NOMESCO Finland
More than seven and less than nine hours
5.6
40.7
123
227
WX704
NOMESCO Finland
Intubation
2.5
40.4
334
1393
1CD02
NOMESCO Finland
NA
7.9
40.2
94
122
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
3.0
40.2
248
867
130
Kela drug reimbursment
Malignant tumour
2.8
40.1
277
1040
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.5
39.2
329
1381
ZX090
NOMESCO Finland
Other technic of radiotherapy
4.3
38.9
149
355
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
5.6
37.8
114
210
D70.82
ICD-10 Finland
Drug-induced neutropenia
5.4
37.7
116
219
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
6.0
37.2
106
182
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
11.9
37.2
69
59
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
5.9
36.5
105
183
HWH99
NOMESCO Finland
Other reoperation in surgery of mammary gland
13.6
36.2
63
47
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
8.0
36.2
83
105
WX702
NOMESCO Finland
Supraglottic ventilation device
2.6
35.7
273
1087
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
4.1
35.4
145
368
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
6.0
35.3
100
171
N02BE01
ATC
paracetamol; systemic, rectal
1.7
34.4
3315
29750
JN4CD
NOMESCO Finland
Very extensive body CT
3.7
34.4
158
444
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.5
34.0
289
1221
LCD04
NOMESCO Finland
Laparoscopic hysterectomy
2.7
34.0
247
956
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
33.8
460
2413
HWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of mammary gland
10.6
33.8
66
63
QB2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in chest
7.5
33.8
81
110
ZX070
NOMESCO Finland
Intensity modified radiotherapy
5.4
33.0
102
194
HWD00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of mammary gland
7.0
33.0
83
121
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
5.3
32.4
101
194
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
8.2
32.4
73
90
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.3
32.2
308
1382
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
32.1
423
2190
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
5.7
31.9
94
169
HAD20
NOMESCO Finland
Liposuction of breast
26.1
31.9
44
17
128
Kela drug reimbursment
Cancers of female genital organs
4.4
31.1
115
266
D48.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Breast
4.0
30.6
126
322
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
3.1
30.2
170
558
WX725
NOMESCO Finland
Noninvasive ventilation
2.8
30.1
208
782
X21
ICPC
Breast sympt/compl female other
3.5
29.9
143
416
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
10.1
29.6
59
59
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
10.7
29.4
57
54
N02AA05
ATC
oxycodone; systemic
2.0
29.2
398
2086
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
6.2
29.1
80
132
JFH00
NOMESCO Finland
Total colectomy and ileorectal anastomosis
22.3
29.1
42
19
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
6.6
28.9
75
115
L02AE02
ATC
leuprorelin; implant, parenteral
3.4
28.5
141
421
Y83.4
ICD-10 Finland
Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
23.8
28.3
40
17
R50.9
ICD-10 Finland
Fever, unspecified
1.9
28.1
474
2687
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
39.2
28.0
35
9
J01DB01
ATC
cefalexin; oral
1.5
28.0
3136
28114
L02AE03
ATC
goserelin; implant
5.0
27.9
91
185
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.9
27.8
117
306
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
5.4
27.7
84
157
PJW99
NOMESCO Finland
Other operation on lymphatic system
10.1
27.6
55
55
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
6.7
27.5
71
108
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.6
27.5
815
5474
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
3.3
27.2
140
431
SPAT1153
SPAT
Removal of sutures
1.5
27.0
1023
7296
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
3.0
27.0
162
557
1511
Kela drug reimbursment
Olaparib
272.9
26.7
27
*
LCA06
NOMESCO Finland
Biopsy of endometrium
1.7
26.7
591
3657
HAD40
NOMESCO Finland
Mastopexy
7.9
26.6
61
78
FM1FN
NOMESCO Finland
Heart function isotope examination
7.8
26.4
61
79
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.8
26.2
503
2975
ZXA00
NOMESCO Finland
Right side
1.6
26.2
836
5715
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
9.1
26.1
55
61
A02BC02
ATC
pantoprazole; systemic
1.4
26.1
2306
19514
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
4.9
26.0
87
182
QBJ00
NOMESCO Finland
Liposuction in trunk
7.1
25.9
64
92
389
Kela drug reimbursment
Olaparib
262.3
25.7
26
*
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
25.5
870
6038
S18
ICPC
Laceration/cut
1.5
25.5
1331
10155
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
6.2
25.4
69
113
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
4.8
25.3
85
179
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.5
25.3
120
348
ZXA05
NOMESCO Finland
Left side
1.6
25.0
773
5236
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
10.8
24.5
47
44
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
7.6
24.3
57
76
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
6.1
24.2
66
109
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
9.2
23.9
50
55
ZXA10
NOMESCO Finland
Bilateral
1.7
23.9
579
3667
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
6.8
23.8
60
89
HA1SA
NOMESCO Finland
Expansion mammography
9.3
23.7
49
53
TQW11
NOMESCO Finland
Vacuum treatment of wound
4.8
23.6
79
166
ZX112
NOMESCO Finland
Subcutaneous
3.8
23.6
101
269
8500/3-C50.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of central portion of breast
7.8
23.4
54
70
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
23.4
319
1669
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
12.9
23.3
41
32
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
23.2
901
6422
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
7.3
23.2
56
78
HA2AT
NOMESCO Finland
Cytology of mammary gland with ultrasound guidance
7.9
23.2
53
68
J01MA12
ATC
levofloxacin; systemic
1.7
22.7
542
3417
1501
Kela drug reimbursment
Palbociclib
7.3
22.4
54
75
PG1BD
NOMESCO Finland
Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft
52.3
22.1
26
5
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.3
22.0
113
349
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
5.4
22.0
66
123
Z80.2
ICD-10 Finland
Family history of malignant neoplasm of other respiratory and intrathoracic organs
+∞
21.9
21
*
M01AE01
ATC
ibuprofen; systemic, rectal
1.6
21.8
3573
33498
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.6
21.4
557
3594
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
6.4
21.2
56
89
M05BX04
ATC
denosumab; parenteral
2.6
21.2
161
640
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.3
20.8
77
180
Z93.3
ICD-10 Finland
Colostomy status
110.6
20.6
22
*
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
5.1
20.6
65
129
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
3.8
20.4
86
227
394
Kela drug reimbursment
Palbociclib
7.0
20.3
50
72
L02BA03
ATC
fulvestrant; parenteral
7.2
20.3
49
69
WX110
NOMESCO Finland
Local anesthesy
1.4
20.1
2618
23149
C50.93
ICD-10 Finland
Malignant tumor in other specified localization in mammary gland other or unspecified histology
10.9
20.1
38
35
JAL30
NOMESCO Finland
Omentectomy
4.4
20.1
73
168
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.7
20.0
143
549
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
6.2
19.8
53
86
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
4.9
19.7
64
131
ZZS55
NOMESCO Finland
Distension of tissue expander
73.9
19.7
22
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
8.3
19.6
43
52
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
200.9
19.6
20
*
HAD55
NOMESCO Finland
Incision of periprosthetic capsule of breast
40.3
19.5
24
6
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
4.6
19.5
67
146
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
3.5
19.4
93
273
ZSH00
NOMESCO Finland
Procedure related to previous procedure classified in chapter H
6.9
19.4
48
70
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
10.7
19.4
37
35
192
Kela drug reimbursment
Fulvestrant
7.0
18.8
46
66
L01XK01
ATC
olaparib; oral
+∞
18.8
18
*
HAB00
NOMESCO Finland
Excision of lesion of mammary gland
2.6
18.7
139
548
WX400
NOMESCO Finland
Inhalation anesthesy
2.2
18.6
194
907
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
6.3
18.6
49
78
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.8
18.4
361
2139
3AA13
NOMESCO Finland
NA
15.1
18.4
30
20
8500/3-C50.8
ICD-O-3
Infiltrating duct carcinoma, NOS, of overlapping lesion of breast
7.5
18.4
43
58
HAA10
NOMESCO Finland
Biopsy of mammary gland
5.7
18.2
52
92
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.1
18.2
211
1033
TQW99
NOMESCO Finland
Other minor procedure on skin
2.4
18.1
152
639
A79
ICPC
Malignancy NOS
4.4
18.1
66
153
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.4
18.1
157
671
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.8
18.0
115
413
Z51.5
ICD-10 Finland
Palliative care
2.5
18.0
148
617
HAC25
NOMESCO Finland
Radical mastectomy
8.7
17.9
38
44
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
8.7
17.9
38
44
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
6.0
17.8
49
83
L01XX46
ATC
[U] olaparib; oral
+∞
17.7
17
*
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.1
17.7
210
1039
C57.0
ICD-10 Finland
Malignant neoplasm: Fallopian tube
9.3
17.6
36
39
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
7.8
17.5
40
52
HA1RA
NOMESCO Finland
Combined assessment of mammary gland (mammography and ultrasound)
3.2
17.5
93
297
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.8
17.4
338
1997
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
2.7
17.4
121
460
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
9.8
17.1
34
35
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
7.1
17.0
41
58
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
5.2
16.9
52
101
N64.9
ICD-10 Finland
Disorder of breast, unspecified
4.1
16.9
66
164
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
16.9
703
5045
ZXE00
NOMESCO Finland
One hour or less
1.4
16.8
1367
11077
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.0
16.7
222
1152
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
7.4
16.6
39
53
C50.50
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication
9.8
16.6
33
34
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.7
16.6
115
435
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
16.5
1307
10545
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
7.7
15.8
36
47
ZSZ00
NOMESCO Finland
Primary repair operation
14.5
15.8
26
18
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
8.4
15.7
34
41
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
4.0
15.6
62
157
WX720
NOMESCO Finland
Own respiration
2.4
15.5
130
549
Z84.8
ICD-10 Finland
Family history of other specified conditions
160.6
15.5
16
*
HAD00
NOMESCO Finland
Augmentation mammoplasty
10.8
15.4
29
27
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
7.4
15.4
36
49
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
9.0
15.4
32
36
8510/3-C50.9
ICD-O-3
Medullary carcinoma, NOS, of breast, NOS
38.2
15.4
19
5
X26
ICPC
Fear of breast cancer female
5.5
15.4
45
83
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
4.9
15.3
49
100
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.8
15.2
280
1624
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
5.7
15.2
43
76
C50.39
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology
8.3
15.2
33
40
TPX15
NOMESCO Finland
Removal of vascular injection port
8.1
15.0
33
41
Z31.6
ICD-10 Finland
General counselling and advice on procreation
4.5
15.0
52
116
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.5
14.9
113
452
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
2.9
14.8
88
304
PJ1AN
NOMESCO Finland
Lymphsystem isotope imaging
12.5
14.8
26
21
8500/3-C50.3
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast
6.0
14.8
40
67
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
56.9
14.8
17
*
JN3AD
NOMESCO Finland
Abdominal CT examination
1.9
14.7
213
1141
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.8
14.7
96
352
L01XE33
ATC
[U] palbociclib; oral
6.8
14.6
36
53
1XC03
NOMESCO Finland
NA
6.8
14.6
36
53
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
14.6
446
2979
L01EF01
ATC
palbociclib; oral
7.9
14.3
32
41
WX002
NOMESCO Finland
Sedation and analgesia
1.5
14.2
557
3935
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
6.1
14.2
38
63
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
3.0
14.1
81
272
ZXC90
NOMESCO Finland
Use of absorbable mesh in surgery
42.6
14.1
17
*
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
2.4
14.0
122
524
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
6.7
14.0
35
53
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.9
14.0
199
1060
121
Kela drug reimbursment
Severe hypofunction of sexual glands
2.8
13.9
91
335
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
5.4
13.9
41
77
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
6.5
13.8
35
54
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
3.9
13.6
55
142
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.0
13.6
43
87
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
2.8
13.6
86
311
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
5.9
13.6
37
63
Z87.5
ICD-10 Finland
Personal history of complications of pregnancy, childbirth and the puerperium
34.1
13.5
17
5
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.8
13.4
215
1192
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
3.0
13.3
76
255
ZSZ10
NOMESCO Finland
Secondary repair operation
9.7
13.2
26
27
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
13.1
476
3305
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.4
12.9
106
442
C50.2
ICD-10 Finland
Malignant neoplasm: Upper-inner quadrant of breast
9.3
12.9
26
28
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
4.9
12.9
41
84
Z51.0
ICD-10 Finland
Radiotherapy session
3.8
12.9
54
145
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
12.7
286
1764
8522/3-C50.9
ICD-O-3
Infiltrating duct and lobular carcinoma of breast, NOS
10.5
12.7
24
23
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
4.3
12.7
46
108
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
2.2
12.6
131
614
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
4.3
12.6
46
109
B01AB04
ATC
dalteparin; parenteral
2.1
12.5
138
663
Z93.2
ICD-10 Finland
Ileostomy status
+∞
12.5
12
*
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
9.3
12.4
25
27
C18.40
ICD-10 Finland
Malignant tumor of the transverse colon without histology
13.2
12.4
21
16
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
4.3
12.4
45
106
GA1CG
NOMESCO Finland
Extensive MRI of chest
14.3
12.2
20
14
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
2.9
12.2
71
244
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
12.1
310
1984
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.0
12.1
161
838
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.8
12.0
211
1208
C50.52
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor
6.6
12.0
30
46
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
3.3
12.0
60
186
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
4.6
12.0
40
87
A02BC05
ATC
esomeprazole; systemic
1.3
11.9
1352
11351
HA1BA
NOMESCO Finland
Extensive X-ray mammography
5.2
11.9
36
70
JFB30
NOMESCO Finland
Right hemicolectomy
4.3
11.9
43
101
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
4.4
11.8
41
93
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
4.8
11.7
38
80
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
5.2
11.6
35
68
Z12.8
ICD-10 Finland
Special screening examination for neoplasms of other sites
65.1
11.6
13
*
ZZS50
NOMESCO Finland
Insertion of tissue expander
22.9
11.6
16
7
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.5
11.5
474
3376
Z80.7
ICD-10 Finland
Family history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
+∞
11.5
11
*
Z82.7
ICD-10 Finland
Family history of congenital malformations, deformations and chromosomal abnormalities
+∞
11.5
11
*
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
2.9
11.4
68
238
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
3.4
11.4
53
156
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
2.9
11.3
66
227
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.8
11.3
185
1037
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
7.9
11.3
25
32
ZXM40
NOMESCO Finland
Use of fluorescent substance
11.8
11.3
20
17
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
11.3
215
1264
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
3.1
11.2
59
190
8461/3-C57.0
ICD-O-3
High grade serous carcinoma of fallopian tube
8.9
11.2
23
26
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
5.9
11.2
30
51
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
3.5
11.1
50
143
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
3.4
11.1
53
159
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
6.1
11.0
29
48
PD1AD
NOMESCO Finland
CT of abdominal aorta and branches
7.8
10.8
24
31
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
3.7
10.8
45
121
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
3.1
10.8
58
190
JFB00
NOMESCO Finland
Partial resection of small intestine
3.5
10.8
49
142
T85.4
ICD-10 Finland
Mechanical complication of breast prosthesis and implant
7.2
10.7
25
35
N06AX16
ATC
venlafaxine; oral
1.4
10.7
499
3642
L01CA04
ATC
vinorelbine; systemic
4.5
10.6
36
80
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
60.2
10.6
12
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.6
10.6
76
298
C18.51
ICD-10 Finland
Malignant tumor of flexura hiealis invasive carcinoma
11.2
10.5
19
17
Z12.3
ICD-10 Finland
Special screening examination for neoplasm of breast
3.5
10.5
48
140
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
3.8
10.4
42
110
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
5.2
10.4
31
60
UJF30
NOMESCO Finland
Ileoscopy through colon
1.6
10.3
286
1867
C50.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of breast
7.1
10.2
24
34
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
7.1
10.2
24
34
HA1HA
NOMESCO Finland
Tomosynthesis mammography
4.2
10.2
37
88
8140/3-C18.6
ICD-O-3
Adenocarcinoma, NOS, of descending colon
23.4
10.2
14
6
QWF00
NOMESCO Finland
Reoperation for insufficiency of suture in plastic surgery of skin
23.4
10.2
14
6
WW500
NOMESCO Finland
Blood transfusion
2.1
10.2
112
543
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
3.2
10.1
52
166
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
6.9
10.1
24
35
SPAT1269
SPAT
Other puncture and/or drainage
4.8
10.0
32
67
C18.61
ICD-10 Finland
Malignant tumor of the colon descending invasive carcinoma
11.3
10.0
18
16
JDD00
NOMESCO Finland
Total gastrectomy and Roux-en-Y oesophagojejunostomy
10.0
10.0
19
19
D24
ICD-10 Finland
Benign neoplasm of breast
2.3
10.0
90
398
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.3
10.0
35
81
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.5
9.9
315
2121
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
2.6
9.9
70
272
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
5.4
9.8
28
52
JAH00
NOMESCO Finland
Laparotomy
2.5
9.8
74
300
5702
FHL
Local lymph node removal (eg armpit, groin)
8.7
9.8
20
23
HAD10
NOMESCO Finland
Augmentation of breast using prosthesis
4.8
9.7
31
65
T81.9
ICD-10 Finland
Unspecified complication of procedure
2.7
9.7
63
234
HA4ST
NOMESCO Finland
Labeling mammary gland pathology with sterotactic guidance
4.5
9.7
33
74
HA3ST
NOMESCO Finland
Removal of lesion of breast with radiological guidance
4.9
9.7
30
61
Z80
ICD-10 Finland
Family history of malignant neoplasm
55.1
9.6
11
*
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
5.3
9.6
28
53
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.5
9.6
75
308
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
4.9
9.6
30
62
C50.5
ICD-10 Finland
Malignant neoplasm: Lower-outer quadrant of breast
8.4
9.5
20
24
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
5.4
9.5
27
50
Z85.0
ICD-10 Finland
Personal history of malignant neoplasm of digestive organs
7.1
9.5
22
31
GD1AD
NOMESCO Finland
Thorax CT examination
2.1
9.5
104
502
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
3.3
9.5
45
136
D05.9
ICD-10 Finland
Carcinoma in situ of breast, unspecified
6.6
9.4
23
35
Z94.0
ICD-10 Finland
Kidney transplant status
+∞
9.4
9
*
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
2.7
9.3
63
239
HA1AE
SPAT
NA
2.2
9.3
88
398
R92
ICD-10 Finland
Abnormal findings on diagnostic imaging of breast
4.9
9.3
29
60
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
6.4
9.2
23
36
JFF10
NOMESCO Finland
Loop enterostomy
6.0
9.2
24
40
WX892
NOMESCO Finland
Monitored bed care
1.7
9.2
171
999
LAE21
NOMESCO Finland
Bilateral laparoscopic oophorectomy
5.7
9.2
25
44
QBJ99
NOMESCO Finland
Other aesthetic correction of skin of trunk
15.6
9.0
14
9
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.4
8.9
413
3006
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
6.5
8.9
22
34
127
Kela drug reimbursment
Transplant complication
18.6
8.9
13
7
9703
FHL
Breast resection
4.0
8.9
34
86
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.8
8.9
151
861
ZZQ70
NOMESCO Finland
Free microvascular graft of lymph nodes
12.5
8.9
15
12
A46
ICD-10 Finland
Erysipelas
1.5
8.8
306
2103
J01MA02
ATC
ciprofloxacin; systemic
1.3
8.8
1115
9413
WB610
NOMESCO Finland
Demanding neoadjuvant therapy of tumour with antibodies
10.7
8.8
16
15
17402
ICD-8 Finland
Malignant neoplasm of breast, Glandulae
10.7
8.8
16
15
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.9
8.7
116
605
N02AX02
ATC
tramadol; systemic, rectal
1.2
8.7
1245
10657
N62
ICD-10 Finland
Hypertrophy of breast
1.7
8.7
163
956
Z80.1
ICD-10 Finland
Family history of malignant neoplasm of trachea, bronchus and lung
50.1
8.7
10
*
JFF23
NOMESCO Finland
Transversostomy
4.5
8.6
29
65
WX004
NOMESCO Finland
Patient-controlled sedation
4.5
8.6
29
65
XX2ET
NOMESCO Finland
NA
16.3
8.5
13
8
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
4.4
8.5
29
66
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.2
8.5
80
362
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
2.7
8.5
55
205
Z12.9
ICD-10 Finland
Special screening examination for neoplasm, unspecified
90.2
8.4
9
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
3.3
8.4
40
122
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.7
8.4
157
921
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
8.3
1235
10604
Z3231
NOMESCO Finland
Registered nurse
1.3
8.3
791
6438
JGB00
NOMESCO Finland
Partial proctectomy and colorectal or coloanal anastomosis
6.2
8.3
21
34
8140/3-C18.4
ICD-O-3
Adenocarcinoma, NOS, of transverse colon
8.5
8.3
17
20
LCD00
NOMESCO Finland
Hysterectomy
1.7
8.3
168
1012
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
9.4
8.3
16
17
JEA00
NOMESCO Finland
Appendectomy
1.6
8.2
210
1345
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
2.2
8.2
76
344
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
2.6
8.2
56
214
TQX05
NOMESCO Finland
Skin puncture, unspecified location
7.5
8.1
18
24
Z87.4
ICD-10 Finland
Personal history of diseases of the genitourinary system
17.2
8.1
12
7
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
2.5
8.1
59
235
C18.22
ICD-10 Finland
Malignant tumor of the colon ascending carcinoma of the adenoma
11.7
8.1
14
12
HA1DM
NOMESCO Finland
Mammary gland very extensive MRI examination with 3 Tesla magnet
11.7
8.1
14
12
8480/3-C50.9
ICD-O-3
Mucinous adenocarcinoma of breast, NOS
11.7
8.1
14
12
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
2.5
8.0
60
244
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
3.3
8.0
38
116
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
3.7
8.0
33
90
1749X
ICD-9 Finland
Malignant neoplasm of female breast, Breast (female), unspecified
13.0
7.9
13
10
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
6.1
7.8
20
33
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
3.8
7.8
31
82
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
5.4
7.8
22
41
XX1XT
NOMESCO Finland
Other puncture with other radiological guidance
5.4
7.8
22
41
8380/3-C56.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of ovary
8.4
7.8
16
19
C50.32
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor
6.9
7.8
18
26
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.5
7.7
57
228
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
3.0
7.7
41
136
J01FF01
ATC
clindamycin; systemic
1.3
7.7
814
6704
8507/3-C50.9
ICD-O-3
Invasive micropapillary carcinoma of breast of breast, NOS
15.0
7.7
12
8
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
15.0
7.7
12
8
Z98.8
ICD-10 Finland
Other specified postsurgical states
5.0
7.7
23
46
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
3.1
7.7
40
131
WF004
NOMESCO Finland
Palliative radiotherapy
2.8
7.7
46
165
JLC30
NOMESCO Finland
Pancreatoduodenectomy
4.6
7.7
25
55
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.5
7.7
57
231
R18
ICD-10 Finland
Ascites
2.7
7.6
50
189
JG1CG
NOMESCO Finland
Extensive MRI of rectum
6.7
7.6
18
27
JG1BG
NOMESCO Finland
MRI of rectum
5.4
7.5
21
39
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.5
7.5
225
1501
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
4.1
7.5
27
66
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
4.0
7.4
28
71
D12.7
ICD-10 Finland
Benign neoplasm: Rectosigmoid junction
4.0
7.4
28
71
ZZA20
NOMESCO Finland
Split skin xenograft
80.2
7.4
8
*
Q85.83
ICD-10 Finland
Gardner syndrome
80.2
7.4
8
*
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
6.5
7.4
18
28
XX4AT
NOMESCO Finland
Other canalization with ultrasound guidance
6.5
7.4
18
28
WF001
NOMESCO Finland
Preoperative radiotherapy
4.1
7.4
27
67
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
5.6
7.4
20
36
E0000UV
ATC
NA
1.2
7.3
1315
11486
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.5
7.3
52
207
WX1CG
NOMESCO Finland
Extensive total body MRI with high intensity magnet
+∞
7.3
7
*
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
2.9
7.3
40
137
JAL00
NOMESCO Finland
Biopsy of peritoneum
3.9
7.2
28
73
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
3.7
7.2
29
78
C56
ICD-10 Finland
Malignant neoplasm of ovary
5.1
7.2
21
41
X19
ICPC
Breast lump/mass female
2.2
7.2
71
332
Z3226
NOMESCO Finland
Physiotherapist
1.3
7.2
532
4183
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
3.5
7.2
31
89
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
7.2
402
3027
JFH01
NOMESCO Finland
Laparoscopic colectomy with ileorectal anastomosis
20.0
7.1
10
5
G03FA01
ATC
norethisterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
0.7
7.1
231
3238
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
3.0
7.1
38
128
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
3.5
7.1
30
85
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
3.8
7.0
28
75
A09AA02
ATC
multienzymes (lipase, protease etc.)
2.5
6.9
52
211
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
5.1
6.9
20
39
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
5.8
6.9
18
31
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
1.6
6.9
180
1162
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
6.9
1781
16082
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.2
6.8
66
305
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
4.8
6.8
21
44
Z2221
NOMESCO Finland
Medical doctor
1.2
6.8
921
7797
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
5.0
6.8
20
40
XF404
NOMESCO Finland
Ambulatory ECG
1.5
6.8
200
1329
QX4YT
NOMESCO Finland
Puncture of superficial collection under ultrasound guidance
6.1
6.8
17
28
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
5.3
6.8
19
36
ZXD20
NOMESCO Finland
Day surgery
1.3
6.7
402
3059
TQW40
NOMESCO Finland
Remowal of suture of skin
1.5
6.7
201
1340
8441/3-C56.9
ICD-O-3
Serous carcinoma, NOS, of ovary
7.2
6.7
15
21
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
6.7
401
3050
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
3.5
6.7
29
84
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.5
6.7
234
1614
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
0.6
6.7
95
1574
G03FA14
ATC
dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
0.6
6.6
102
1658
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
2.8
6.6
39
139
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
6.4
6.6
16
25
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
2.5
6.6
47
187
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
5.5
6.6
18
33
C50.09
ICD-10 Finland
Malignant tumor of nipple and areola, other or undeterminated histology
12.3
6.6
11
9
K91.4
ICD-10 Finland
Colostomy and enterostomy malfunction
12.3
6.6
11
9
WX872
NOMESCO Finland
Intensive care
2.0
6.6
76
380
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
8.7
6.5
13
15
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
6.8
6.5
15
22
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
1.9
6.5
82
425
A04AA03
ATC
tropisetron; systemic
5.0
6.5
19
38
AA1AD
NOMESCO Finland
CT of head and brain
1.3
6.4
548
4387
N64.8
ICD-10 Finland
Other specified disorders of breast
3.3
6.4
29
87
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.5
6.4
187
1241
HA1ST
NOMESCO Finland
Biopsy of mammary gland with sterotactic guidance
7.4
6.4
14
19
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
7.4
6.4
14
19
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.0
6.4
72
355
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
4.9
6.3
19
39
WB131
NOMESCO Finland
Very demanding neoadjuvant cytostatic therapy
9.3
6.3
12
13
WX1DM
NOMESCO Finland
Very extensive total body MRI with 3 Tesla magnet
+∞
6.2
6
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
+∞
6.2
6
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
26.7
6.2
8
*
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
5.0
6.2
18
36
J01FA10
ATC
azithromycin; systemic
1.2
6.1
2180
20154
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
5.3
6.1
17
32
R06AE07
ATC
cetirizine; oral
1.2
6.1
1565
14067
JGB30
NOMESCO Finland
Abdominoperineal excision of rectum
12.5
6.1
10
8
N61
ICD-10 Finland
Inflammatory disorders of breast
1.8
6.0
98
554
TQD05
NOMESCO Finland
Puncture of skin of lower limb
10.0
6.0
11
11
HAD57
NOMESCO Finland
Resection of periprosthetic capsule of breast
10.0
6.0
11
11
C48.89
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor
10.0
6.0
11
11
ZXD05
NOMESCO Finland
Urgent procedure
1.2
6.0
937
8040
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768793) Breast Pathology biopsy report
604
1099
6.20
323.31
1.4
1.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
971
2671
4.36
320.15
4.6
3.1
u/ml
24.3
47.4
6.07
934
2583
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1050
3125
4.08
310.26
5.3
3.9
ug/l
6.9
35.9
1.56
800
2426
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
493
784
6.94
300.93
4.2
3.7
u/ml
40.2
30.4
0.59
478
761
(4035726)
894
3040
3.42
209.99
1.5
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
256
369
7.30
169.62
1.1
1.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2710
17796
2.32
158.21
9.8
5.4
umol/l
9.5
10.3
4.23
2632
16816
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2562
16957
2.19
139.47
4.5
3.6
—
—
—
0
0
(3002256) Pathology report gross observation
989
4824
2.35
109.89
1.5
1.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
3499
27561
2.23
105.45
11.0
6.7
u/l
75.1
75.4
0.21
3400
25968
(40768804) Tissue Pathology biopsy report
2337
16197
1.92
97.83
2.5
2.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
339
1034
3.46
91.29
3.5
3.3
u/ml
291.5
1570.1
0.71
291
876
(3044640) Blood type and Crossmatch panel - Blood
1727
11057
1.91
89.75
2.5
2.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
310
974
3.34
79.45
1.4
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2261
16182
1.80
78.94
6.9
5.1
mmol/l
1.2
1.2
4.60
1870
13687
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2086
14583
1.80
78.76
5.6
4.6
mmol/l
1.2
1.2
2.06
1938
13237
(3032080) INR in Blood by Coagulation assay
1734
11469
1.83
78.63
5.9
5.5
inr
1.1
1.1
4.50
489
3429
(3013650) Neutrophils [#/volume] in Blood by Automated count
2781
21270
1.81
76.59
12.5
8.6
e9/l
3.5
3.9
29.18
2529
18613
(3024561) Albumin [Mass/volume] in Serum or Plasma
1995
14009
1.76
72.11
5.8
4.0
g/l
35.7
36.4
7.22
1880
13061
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1318
8290
1.84
68.31
2.4
2.0
—
—
—
0
0
(4281824)
185
458
4.17
67.12
1.1
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1699
11584
1.75
66.58
5.9
3.1
mmol/l
2.4
2.4
0.52
1544
10279
(3023368) Bacteria identified in Blood by Culture
1190
7359
1.84
64.53
4.3
3.7
—
—
—
0
0
(3039000) Anion gap in Blood
186
564
3.40
50.24
6.3
6.5
mmol/l
10.5
11.1
1.70
163
503
(3018572) Chloride [Moles/volume] in Blood
186
565
3.39
50.10
6.3
6.5
mmol/l
105.9
105.4
0.65
163
504
(3047181) Lactate [Moles/volume] in Blood
238
846
2.91
49.12
5.7
5.4
mmol/l
1.2
1.2
0.22
205
738
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
322
1358
2.48
47.38
7.6
8.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
545
2878
2.02
46.16
2.4
2.0
g/l
0.2
0.2
2.98
525
2704
(3013826) Glucose [Moles/volume] in Serum or Plasma
2442
19450
1.56
45.20
4.7
3.7
mmol/l
6.4
6.5
0.91
2292
17884
(3002173) Hemoglobin [Mass/volume] in Arterial blood
468
2386
2.07
43.54
7.5
7.2
g/l
121.0
122.5
1.01
436
2297
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
106
247
4.37
41.64
1.2
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
677
4032
1.80
39.29
1.4
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
713
4315
1.78
39.18
2.0
1.8
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
524
2914
1.90
37.77
7.1
6.5
kpa
5.1
5.1
0.26
500
2785
(3027801) Oxygen [Partial pressure] in Arterial blood
524
2915
1.90
37.73
7.1
6.5
kpa
15.2
13.0
12.51
497
2789
(3016502) Oxygen saturation in Arterial blood
469
2523
1.96
37.31
7.4
7.0
%
97.1
96.0
3.39
442
2430
(3003396) Base excess in Arterial blood by calculation
521
2905
1.90
37.23
7.1
6.5
mmol/l
0.9
1.1
0.85
423
2260
(42870588) Differential panel, method unspecified - Blood
1585
11846
1.52
36.73
4.7
5.6
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
170
591
2.95
36.50
4.6
3.6
u/ml
113.4
702.7
0.78
157
547
(3007930) Methemoglobin/Hemoglobin.total in Blood
238
996
2.47
35.50
5.5
4.8
%
1.0
0.9
1.97
213
930
(3033658) Prothrombin time (PT) actual/Normal
1228
8749
1.56
35.11
3.8
3.1
%
95.7
96.3
0.46
1201
8509
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
237
1001
2.44
34.64
5.5
4.7
%
1.7
1.7
0.25
212
930
(3018418) pH of Serum or Plasma
1332
9698
1.53
34.36
4.2
3.3
ph
7.4
7.4
1.81
307
1762
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1608
12361
1.47
31.07
4.6
2.9
u/l
30.7
31.2
0.18
1549
11805
(3012095) Magnesium [Moles/volume] in Serum or Plasma
738
4781
1.65
30.97
3.4
2.8
mmol/l
0.8
0.8
0.57
693
4469
(3019550) Sodium [Moles/volume] in Serum or Plasma
4083
38042
1.82
28.46
15.8
11.1
mmol/l
139.8
139.7
0.98
4009
37091
(3023103) Potassium [Moles/volume] in Serum or Plasma
4088
38185
1.80
27.10
16.0
11.2
mmol/l
3.9
3.9
1.83
4009
37148
(3008152) Bicarbonate [Moles/volume] in Arterial blood
300
1550
2.00
26.58
6.3
6.3
mmol/l
24.7
24.6
0.22
271
1433
(3031040) Bacteria [#/volume] in Urine by Automated count
2772
23984
1.41
25.81
4.1
3.9
e6/l
1242.2
1824.7
0.34
21
273
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
468
2820
1.74
25.46
3.2
2.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
105
342
3.12
25.32
1.2
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
1225
9230
1.45
25.07
10.2
6.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1397
10802
1.43
24.77
3.0
2.3
u/l
57.9
56.8
0.35
1319
9975
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
4059
38018
1.71
24.22
14.9
10.7
mg/l
22.1
20.6
2.22
3331
29224
(3044889) 12 lead EKG panel
2839
24803
1.39
24.03
3.5
3.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1918
15833
1.37
22.43
2.3
2.2
nmol/l
78.3
76.4
2.44
1792
14586
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
190
885
2.20
22.14
1.4
1.4
nmol/l
0.4
0.4
0.83
145
685
(3002385) Erythrocyte distribution width [Ratio]
3546
32407
1.45
21.77
19.9
13.2
%
13.6
13.5
0.55
3502
31756
(3002030) Lymphocytes/100 leukocytes in Blood
2120
17840
1.36
21.65
4.9
5.7
%
28.6
29.4
2.30
1987
16666
(3019060) Gas panel - Arterial blood
289
1586
1.88
21.39
5.2
4.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
2054
17229
1.35
21.29
5.1
5.9
%
8.5
8.2
2.83
1941
16169
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
656
4498
1.54
20.98
1.8
1.7
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
2040
17141
1.35
20.69
4.9
5.7
%
2.7
2.8
0.80
1914
15978
(3018010) Neutrophils/100 leukocytes in Blood
2081
17591
1.34
20.03
4.7
5.5
%
56.2
56.4
0.34
1963
16494
(3003694) ABO and Rh group [Type] in Blood
1361
10861
1.36
18.84
1.5
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
125
522
2.43
18.81
1.3
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
4209
40184
1.77
18.70
15.5
10.0
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
1962
16575
1.33
18.39
4.9
5.7
%
0.7
0.7
0.28
1841
15455
(3014576) Chloride [Moles/volume] in Serum or Plasma
490
3288
1.55
17.10
8.0
5.9
mmol/l
105.3
104.6
3.21
473
3223
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
459
3053
1.56
16.65
1.7
1.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
70
232
3.05
16.51
1.3
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
567
4008
1.47
15.37
3.0
2.1
umol/l
6.6
7.2
0.33
497
3422
(3037467) Urinalysis macro (dipstick) panel - Urine
2804
25210
1.30
15.32
4.2
3.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
457
3094
1.53
15.26
1.8
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
389
2544
1.58
15.16
3.8
3.1
mmol/l
1.2
1.2
0.14
349
2223
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4223
40590
1.69
15.13
13.2
9.0
u/l
25.6
25.2
0.50
4137
39372
(3019225) pH of Specimen
462
3146
1.52
15.01
3.9
3.3
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
194
1052
1.88
14.93
1.8
1.7
%
96.7
95.9
0.18
173
960
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
129
620
2.11
13.99
1.5
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
330
2126
1.60
13.69
1.6
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
129
627
2.09
13.60
1.4
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
80
317
2.55
13.56
1.1
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
299
1895
1.62
13.28
2.3
2.2
ng/l
163.3
111.9
0.40
261
1708
(3019198) Lymphocytes [#/volume] in Blood
2159
18970
1.27
13.27
4.8
5.6
e9/l
1.8
2.0
10.36
1883
16889
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
178
978
1.85
13.18
2.0
2.0
%
172.1
172.6
0.03
172
931
(3018677) aPTT in Platelet poor plasma by Coagulation assay
581
4256
1.42
12.91
2.0
1.8
s
29.0
29.3
0.57
555
4125
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
744
5692
1.37
12.75
3.2
2.9
ng/l
136.8
284.0
1.61
497
3669
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
144
746
1.96
12.75
1.5
1.3
ug/l
2.7
4.2
1.58
116
665
(3013115) Eosinophils [#/volume] in Blood
2164
19082
1.26
12.67
5.0
5.8
e9/l
0.2
0.2
4.79
1896
16944
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
165
898
1.87
12.60
1.9
2.0
g/l
3.7
3.7
0.04
159
846
(3006315) Basophils [#/volume] in Blood
2093
18415
1.26
12.38
4.8
5.6
e9/l
0.0
0.0
3.06
1802
16010
(3007461) Platelets [#/volume] in Blood
4391
42894
2.13
12.25
24.1
16.2
e9/l
257.3
263.6
9.74
4321
41937
(3035941) MCH [Entitic mass]
4392
42921
2.12
12.01
24.0
16.1
pg
30.2
30.2
2.09
4355
42444
(3024731) MCV [Entitic volume]
4392
42922
2.12
12.00
24.0
16.1
fl
90.8
90.6
3.75
4355
42447
(40768797) Stomach Pathology biopsy report
666
5053
1.37
11.97
1.4
1.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
2082
18351
1.25
11.97
4.8
5.6
e9/l
0.5
0.5
0.67
1796
15973
(3026361) Erythrocytes [#/volume] in Blood
4392
42929
2.11
11.87
24.0
16.2
e12/l
4.4
4.5
31.62
4315
41893
(40758358) Immune stain study
17
23
7.42
11.83
1.0
1.0
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
4392
42933
2.11
11.81
24.1
16.2
e9/l
6.3
6.6
19.38
4313
41882
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
167
933
1.82
11.76
1.4
1.4
u/l
30.9
27.0
0.68
152
776
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
255
1604
1.63
11.69
8.7
8.0
%
0.8
0.7
3.05
255
1592
(3014111) Lactate [Moles/volume] in Serum or Plasma
343
2311
1.52
11.67
6.9
6.0
mmol/l
1.2
1.3
0.36
335
2231
(3000963) Hemoglobin [Mass/volume] in Blood
4391
42942
2.08
11.42
24.2
16.3
g/l
132.3
134.9
35.11
4353
42460
(3007853) Bacteria identified in Skin by Aerobe culture
522
3836
1.41
11.33
1.6
1.6
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
253
1611
1.60
11.04
8.7
7.9
%
1.3
1.3
0.63
253
1601
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
80
350
2.31
11.01
1.3
1.1
u/l
62.9
53.9
1.15
51
244
(3004789) Transferrin [Mass/volume] in Serum or Plasma
569
4266
1.38
10.96
2.1
2.0
g/l
2.4
2.4
0.22
533
3942
(3036489) Thrombin time
208
1265
1.68
10.90
1.7
1.7
s
21.2
20.8
0.72
176
1063
(36304419) Bacteria [Presence] in Urine
1063
8762
1.28
10.50
2.7
2.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
90
423
2.15
10.44
1.5
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
312
2116
1.51
10.30
8.0
7.0
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
616
4726
1.35
10.23
2.1
2.0
umol/l
13.4
14.1
1.51
573
4380
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
750
5923
1.32
10.22
3.8
2.7
mmol/l
2.4
2.4
1.44
676
5167
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
1143
9546
1.26
10.07
1.5
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
518
3888
1.38
9.87
2.1
2.1
%
22.8
23.7
0.74
421
3351
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
46
163
2.84
9.78
1.2
1.1
u/l
14.7
18.5
0.52
39
128
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
46
164
2.82
9.67
1.2
1.1
u/l
69.9
76.9
0.45
39
133
(3026782) Osmolality of Urine
753
5993
1.31
9.66
2.6
2.3
mosm/kgh2o
532.0
533.2
0.05
652
5057
(3002582) Erythrocytes [#/volume] in Urine
1142
9581
1.26
9.61
2.9
2.7
e6/l
55.6
78.7
0.49
850
7162
(3030467) Casts [#/volume] in Urine by Automated count
1060
8816
1.26
9.60
2.8
2.6
e6/l
0.4
0.4
0.09
773
6477
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
117
625
1.90
9.56
2.8
2.6
u/ml
0.4
0.4
0.02
64
339
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
413
3014
1.41
9.30
4.0
3.8
u/l
233.2
236.8
0.22
392
2852
(3049717) Cytology report of Urine Cyto stain
142
814
1.77
9.25
2.9
2.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
3783
36129
1.30
9.09
17.4
11.7
%
39.2
39.9
5.39
2886
28392
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
32
96
3.35
9.02
3.9
2.9
ng/l
272.2
88.5
0.46
13
42
(3003458) Phosphate [Moles/volume] in Serum or Plasma
477
3597
1.36
8.81
4.2
3.7
mmol/l
1.0
1.0
0.49
449
3330
(3026008) Bacteria identified in Urine by Culture
1191
10123
1.24
8.79
2.8
2.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
402
2982
1.38
8.22
3.6
3.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
206
1343
1.56
8.20
9.5
8.3
mmol/l
24.6
24.4
0.50
201
1268
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
107
591
1.83
7.94
1.1
1.1
%
119.2
120.1
0.11
98
532
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
31
99
3.15
7.94
1.4
1.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
31
99
3.15
7.94
1.4
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
31
100
3.11
7.81
1.4
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
58
258
2.26
7.79
1.6
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
156
964
1.64
7.78
1.4
1.4
ug/g
266.8
291.1
0.69
95
517
(3018095) Leukocytes [#/volume] in Urine
1357
11842
1.21
7.52
3.4
3.1
e6/l
64.3
78.2
0.57
941
7907
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
134
807
1.68
7.40
1.5
1.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
434
3314
1.34
7.38
2.6
2.2
u/l
47.1
52.4
0.13
390
2807
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1115
9568
1.22
7.30
1.8
1.6
mmol/l
1.4
1.4
0.23
948
8228
(3035637) Corticotropin [Mass/volume] in Plasma
82
433
1.91
7.04
1.6
1.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
405
3083
1.34
7.03
1.5
1.3
iu/l
30.5
29.8
0.15
365
2695
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3710
35586
1.25
7.02
14.9
9.6
ml/min/173m2
87.3
86.7
1.02
3180
29090
(3021960) Folate [Moles/volume] in Serum or Plasma
846
7086
1.24
6.95
1.5
1.5
nmol/l
21.8
21.3
0.51
737
6151
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
606
4897
1.27
6.78
2.6
2.4
e6/l
2.4
3.8
3.07
309
2496
(3013512) EKG study
1035
8906
1.21
6.48
3.3
3.0
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
174
1159
1.52
6.36
1.4
1.3
u/l
16.3
12.2
2.48
155
966
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
60
296
2.04
6.29
1.5
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
34
131
2.61
6.28
1.4
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
34
131
2.61
6.28
1.4
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
34
131
2.61
6.28
1.4
1.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
308
2293
1.37
6.19
3.4
2.8
ng/l
74.2
72.2
0.19
267
2000
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
34
132
2.59
6.19
1.4
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1774
16070
1.17
6.09
10.3
8.1
e9/l
0.0
0.0
1.25
1437
13079
(44790048)
62
316
1.98
5.96
1.5
1.3
—
—
—
0
0
(44790047)
62
316
1.98
5.96
1.5
1.3
—
—
—
0
0
(44806118)
62
316
1.98
5.96
1.5
1.3
—
—
—
0
0
(44790049)
62
316
1.98
5.96
1.5
1.3
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
115
707
1.64
5.94
2.7
2.6
%
13.3
13.2
0.82
115
698
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
5
267
0.19
5.88
18.0
17.2
nmol/l
1437.8
5109.1
—
5
257
(3041096) Erythrocytes [Presence] in Urine by Automated
1141
9985
1.19
5.88
3.0
2.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
74
405
1.84
5.77
1.3
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
956
8248
1.20
5.75
1.6
1.6
mg/l
1.1
1.0
0.45
740
6214
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
5
262
0.19
5.73
14.6
12.3
nmol/l
715.8
864.8
—
5
250
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
16
42
3.82
5.53
1.0
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
83
478
1.75
5.48
1.3
1.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
92
552
1.68
5.26
2.9
3.1
mmol/l
2.0
2.4
0.90
70
362
(3013707) Erythrocyte sedimentation rate by Westergren method
2945
27900
1.16
5.26
3.7
3.8
mm/h
10.9
10.7
0.35
2735
26149
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
0
+∞
5.21
1.2
0.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
777
6634
1.21
5.18
2.4
2.2
e6/l
7.2
7.4
0.10
680
5757
(4306422)
101
625
1.63
5.14
1.2
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
46
223
2.07
5.12
1.5
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
46
223
2.07
5.12
1.5
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
46
223
2.07
5.12
1.5
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
942
8195
1.19
5.11
2.2
2.1
mg/l
2.6
2.8
1.58
825
7035
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
15
41
3.67
4.92
1.0
1.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
44
214
2.07
4.87
1.8
1.5
u/l
6.2
4.6
0.35
22
105
(3020779) Urea [Moles/volume] in Serum or Plasma
268
2034
1.34
4.81
5.6
4.5
mmol/l
7.6
7.8
0.19
259
1955
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
85
515
1.66
4.73
2.9
2.0
iu/ml
280.8
535.4
—
6
37
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
60
329
1.83
4.72
1.3
1.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1277
11457
1.16
4.68
2.7
2.7
ng/l
20.9
82.7
0.65
729
6188
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
18
58
3.11
4.63
1.7
2.6
—
—
—
0
0
(4034850)
77
1250
0.61
4.53
7.9
8.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
282
2183
1.31
4.43
2.2
2.1
u/l
4971.9
5315.9
0.06
93
857
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
59
329
1.80
4.42
1.2
1.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
171
1225
1.41
4.42
1.1
1.1
u/ml
3.0
6.3
0.87
19
168
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
120
805
1.50
4.36
2.6
2.6
—
—
—
0
0
(3010421) pH of Blood
103
670
1.55
4.32
2.9
3.1
ph
7.4
7.4
0.02
90
544
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
97
623
1.57
4.30
1.1
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
789
6860
1.18
4.25
2.4
2.3
ng/l
799.2
811.9
0.02
670
5678
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
628
5351
1.20
4.25
2.4
2.3
e6/l
1.1
1.2
0.33
329
2929
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
165
1185
1.41
4.22
1.9
1.8
—
—
—
0
0
(4268621)
69
411
1.69
4.14
2.2
2.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
353
2840
1.26
4.13
1.9
2.4
%
1.9
1.7
1.06
318
2533
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
44
229
1.93
4.10
2.0
2.3
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
13
37
3.52
4.04
33.4
7.8
ug/l
110.8
108.2
0.04
13
31
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
39
197
1.99
3.96
1.4
1.1
u/l
17.1
20.9
0.24
34
168
(3017732) Neutrophils [#/volume] in Blood
337
2712
1.26
3.94
2.5
2.5
e9/l
4.0
4.1
0.19
276
2215
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
94
613
1.54
3.93
1.1
1.2
u/ml
1.4
3.8
2.59
31
196
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
128
890
1.45
3.93
2.1
1.9
ug/l
1.9
2.3
0.20
112
798
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
50
276
1.82
3.91
1.0
1.1
ratio
1.0
1.0
1.58
19
98
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
40
205
1.96
3.91
1.0
1.0
%
102.8
92.8
1.57
32
160
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
349
2832
1.25
3.81
3.4
3.3
pmol/l
4.5
4.5
0.83
321
2526
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
45
243
1.86
3.78
1.9
2.3
e6/l
608.8
496.9
0.70
33
206
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
59
347
1.71
3.74
1.3
1.4
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
44
237
1.87
3.73
1.9
2.3
e9/l
0.3
0.2
0.85
35
204
(3019309) Folate [Moles/volume] in Red Blood Cells
603
5188
1.19
3.67
1.8
1.7
nmol/l
1147.8
1176.9
0.37
473
4010
(40768441) Liver Pathology biopsy report
49
275
1.79
3.65
1.1
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
183
1373
1.35
3.63
2.2
2.0
nmol/l
10.3
11.3
0.63
164
1206
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1454
13351
1.13
3.63
1.9
1.8
pmol/l
100.9
98.5
1.05
748
6759
(3023520) Reticulocytes [#/volume] in Blood
258
2034
1.28
3.59
2.1
2.4
e9/l
69.8
71.0
0.19
179
1484
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
84
1264
0.66
3.59
1.6
1.6
iu/ml
0.2
0.3
0.23
18
252
(3034426) Prothrombin time (PT)
28
130
2.16
3.57
1.0
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1917
17921
1.12
3.52
2.9
2.7
ug/l
106.8
91.3
1.69
1816
16879
(3009261) Glucose [Presence] in Urine by Test strip
1949
18238
1.12
3.51
3.3
3.3
estimate
0.0
0.0
0.18
381
3205
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
47
264
1.79
3.51
1.4
1.5
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
79
510
1.56
3.49
2.1
1.3
nmol/l
0.5
2.8
0.52
79
494
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
90
599
1.51
3.47
1.2
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
90
599
1.51
3.47
1.2
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2771
26471
1.12
3.45
3.3
2.8
u/l
44.5
39.5
2.29
2635
25061
(40760892) CBC W Ordered Manual Differential panel - Blood
972
8719
1.15
3.44
3.2
4.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
416
3479
1.22
3.44
2.7
2.2
nmol/l
390.1
374.3
0.77
389
3199
(3021601) Nitrite [Presence] in Urine by Test strip
1931
18075
1.12
3.44
4.6
4.4
estimate
0.0
0.0
0.80
380
3241
(36660697) Celiac disease serology panel - Serum
404
3373
1.22
3.40
1.2
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
78
506
1.55
3.39
1.1
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3511
36074
0.88
3.21
3.4
3.5
mmol/l
1.3
1.3
0.16
3276
33686
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
781
6931
1.15
3.21
1.7
1.6
pmol/l
40061126.6
41570639.6
0.02
659
5961
(3052851) Hemolysis interference index of Serum or Plasma
132
961
1.38
3.20
2.6
2.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
183
1402
1.32
3.19
1.6
1.8
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
11
33
3.34
3.19
1.8
1.5
mg/l
0.7
1.5
—
5
20
(3051651) Icteric interference index of Serum or Plasma
34
179
1.91
3.13
2.4
2.7
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
17
67
2.54
3.12
1.5
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
197
1536
1.30
3.04
1.5
1.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
48
285
1.69
3.01
7.4
6.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
45
263
1.72
2.98
1.5
2.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
27
134
2.02
2.95
1.0
1.1
%
100.1
92.6
—
10
59
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2945
28346
1.11
2.93
3.4
3.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1906
17940
1.11
2.92
3.3
3.3
estimate
0.0
0.0
0.50
380
3178
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
26
128
2.04
2.91
1.0
1.2
%
109.7
95.7
—
9
56
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
10
30
3.34
2.90
1.1
1.4
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
86
591
1.46
2.90
1.2
1.2
u/ml
3.5
4.5
0.34
38
232
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
34
185
1.84
2.86
1.3
1.6
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
129
957
1.36
2.83
2.0
1.9
mg/l
9.9
10.5
0.48
124
898
(21494755) Public health laboratory ask at order entry panel
425
4951
0.84
2.83
1.3
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
196
1547
1.28
2.78
1.5
1.7
—
—
—
0
0
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
10
31
3.23
2.77
1.8
1.5
mg/l
4.5
1.3
—
5
23
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
10
31
3.23
2.77
1.8
1.5
mg/l
0.6
1.0
—
5
19
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
10
31
3.23
2.77
1.8
1.5
mg/l
4.5
1.5
—
5
24
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
98
698
1.41
2.75
3.0
3.5
%
56.2
56.4
0.05
98
698
(3051611) Lipemic interference index of Serum or Plasma
49
301
1.63
2.73
2.4
2.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
103
741
1.40
2.73
1.1
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
50
309
1.63
2.72
1.2
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
24
118
2.04
2.71
2.1
3.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
457
3945
1.18
2.70
5.3
4.4
ug/l
2.0
2.4
0.87
417
3543
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3678
35919
1.13
2.66
5.2
4.9
mu/l
1.8
2.1
1.93
3473
33633
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
192
1522
1.27
2.64
1.9
1.9
u/l
40.4
39.6
0.25
178
1390
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3667
37467
0.88
2.61
3.9
3.9
mmol/l
1.6
1.5
3.59
3435
35165
(3037121) Protein [Mass/volume] in Urine
131
989
1.33
2.59
3.6
2.9
g/l
0.1
0.2
2.44
52
382
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
115
853
1.36
2.56
1.5
2.1
ug/l
237.7
539.5
1.41
98
782
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
5
7
7.15
2.55
1.0
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
96
692
1.40
2.54
3.1
2.2
mg/l
1.3
1.3
0.18
86
646
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
71
486
1.47
2.49
1.2
1.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
65
437
1.49
2.49
2.6
2.7
%
1.3
1.4
0.17
54
342
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3214
31185
1.11
2.49
4.4
4.2
pmol/l
14.6
14.5
0.61
3023
29003
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
372
3189
1.18
2.42
4.2
3.9
%
20.8
21.1
0.17
163
1443
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
170
2131
0.79
2.39
1.5
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
89
642
1.39
2.37
1.1
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
44
274
1.61
2.37
1.0
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
38
228
1.67
2.36
1.3
1.6
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
12
46
2.61
2.35
3.0
1.7
pmol/l
68.1
49.6
0.20
12
40
(3017704) Immunofixation for Urine
23
118
1.95
2.35
1.4
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
139
1078
1.30
2.31
1.7
1.7
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
22
112
1.97
2.30
2.1
2.1
mmol/l
8.6
9.7
—
8
86
(40767503) Oxygen content in Capillary blood by calculation
71
496
1.44
2.27
1.9
2.3
%
17.8
16.4
1.69
27
248
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
26
141
1.85
2.27
1.1
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3694
37661
0.89
2.25
3.9
3.9
mmol/l
4.9
4.9
0.92
3477
35503
(3011412) CD3 cells [#/volume] in Blood
52
342
1.53
2.24
1.8
2.2
e9/l
1.4
1.3
0.48
30
217
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
12
271
0.44
2.22
1.5
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3748
38170
0.89
2.19
4.3
4.3
mmol/l
2.9
2.9
0.65
3495
35744
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
11
42
2.62
2.18
1.1
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
136
1062
1.29
2.17
1.5
1.8
g/l
1.4
1.5
0.52
110
917
(1616796) Gas panel - Central venous blood
74
527
1.41
2.15
2.6
2.8
—
—
—
0
0
(3035880) pH of Pleural fluid
20
101
1.98
2.15
1.1
1.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
36
219
1.65
2.15
1.4
1.4
e6/l
62202.0
98887.5
0.30
22
114
(3052592) Norovirus Ag [Presence] in Stool
13
55
2.37
2.12
1.3
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
245
2053
1.20
2.09
1.4
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
25
138
1.82
2.08
1.1
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
35
556
0.63
2.06
1.1
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
37
230
1.61
2.04
1.2
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
261
3075
0.84
2.04
1.7
1.7
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
12
50
2.40
2.02
1.3
1.4
%
24.3
20.0
0.19
12
43
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
65
460
1.42
1.98
5.9
4.6
u/ml
46.1
70.2
0.48
18
128
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
542
6034
0.88
1.97
2.1
2.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
37
572
0.64
1.95
1.3
1.1
iu/ml
30.7
16909.4
0.56
11
143
(3023199) Leukocytes [#/volume] in Pleural fluid
39
249
1.57
1.95
1.4
1.4
e6/l
3324.4
2895.3
0.13
31
170
(3044009) aPTT.lupus sensitive (LA screen)
9
33
2.73
1.93
1.0
1.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
21
113
1.86
1.91
3.4
2.1
ug/l
1.6
0.9
0.68
21
103
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
14
65
2.16
1.87
1.4
1.2
nmol/l
0.2
0.4
—
7
40
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
12
52
2.31
1.87
1.3
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
31
189
1.64
1.87
1.4
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
129
1023
1.27
1.86
1.1
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
42
276
1.53
1.86
1.6
2.0
%
14.4
13.2
0.20
28
138
(3019174) dRVVT (LA screen)
9
34
2.65
1.86
1.0
1.2
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
15
72
2.09
1.86
1.5
1.1
umol/24h
0.6
0.7
—
9
41
(3000060) B lymphocytes [#/volume] in Blood
20
107
1.87
1.86
1.3
2.2
e6/l
5280.0
134.0
—
8
62
(3042631) Mycobacterium sp identified in Specimen
46
309
1.49
1.85
1.9
2.7
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
30
182
1.65
1.84
1.3
1.6
%
136.5
129.6
0.22
30
171
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
56
394
1.43
1.79
1.1
1.2
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
8
29
2.76
1.79
2.0
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
36
232
1.56
1.75
1.3
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
275
2370
1.17
1.75
3.0
2.8
ug/l
0.8
0.7
0.29
179
1479
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
202
1696
1.20
1.74
2.4
2.3
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
12
54
2.23
1.73
1.0
1.2
mmol/l
3.2
3.2
0.05
12
47
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
47
322
1.46
1.73
1.1
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
265
2281
1.17
1.71
1.2
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1475
13983
1.08
1.71
3.4
3.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
17
89
1.91
1.69
1.1
1.1
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
26
156
1.67
1.68
1.7
1.4
u/l
9.7
12.1
2.21
26
149
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
84
642
1.31
1.64
2.1
2.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
244
2831
0.85
1.63
1.2
1.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
51
360
1.42
1.63
1.7
1.7
%
46.4
55.4
0.80
34
217
(3014148) Varicella zoster virus Ab [Titer] in Serum
35
521
0.67
1.59
1.2
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
78
593
1.32
1.59
1.2
1.1
u/ml
97.5
114.8
0.84
20
135
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
56
404
1.39
1.59
1.1
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
56
404
1.39
1.59
1.1
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
459
4132
1.12
1.58
3.9
4.0
%
32.8
32.2
0.57
326
2863
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
304
2670
1.15
1.53
4.5
2.3
ml/min/173m2
75.8
73.4
0.55
129
1007
(3020393) Adenovirus Ag [Presence] in Stool
8
33
2.43
1.53
1.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
32
208
1.54
1.53
1.3
1.2
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
6
142
0.42
1.51
2.3
2.3
nmol/l
125.0
157.7
—
6
121
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
56
408
1.38
1.51
1.1
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
55
400
1.38
1.50
1.1
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
227
2622
0.86
1.46
3.3
3.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
122
996
1.23
1.44
2.1
2.6
mmol/l
25.2
25.0
0.36
115
927
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
43
602
0.71
1.43
2.0
2.4
ug/min
116.7
76.3
0.17
24
369
(3008401) Mugwort IgE Ab [Units/volume] in Serum
63
831
0.75
1.43
1.1
1.1
u/ml
0.2
1.3
3.87
24
327
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
9
39
2.31
1.43
1.3
1.1
umol/24h
1.5
1.7
—
9
39
(3003181) Sodium [Moles/volume] in Urine
59
439
1.35
1.42
1.3
1.4
mmol/l
72.1
64.8
0.44
48
347
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
62
465
1.34
1.42
2.2
1.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
67
874
0.76
1.41
1.1
1.1
u/ml
1.9
5.6
3.62
28
434
(3015736) pH of Urine
1446
13785
1.07
1.41
3.0
3.1
—
5.9
—
0
9
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
67
873
0.76
1.40
1.2
1.2
—
19.4
—
0
15
(3020491) Glucose [Moles/volume] in Blood
37
254
1.46
1.40
1.8
1.8
mmol/l
6.4
6.4
0.03
30
189
(3036782) Glucose [Moles/volume] in Pleural fluid
31
205
1.52
1.40
1.2
1.3
mmol/l
6.0
6.2
0.10
31
192
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
9
40
2.25
1.40
1.4
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
9
40
2.25
1.40
1.0
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
89
1118
0.79
1.39
1.2
1.3
u/ml
3.6
5.9
—
9
112
(3048929) Epstein Barr virus Ab [Presence] in Serum
147
1229
1.20
1.38
1.2
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
198
0.50
1.38
1.0
1.1
miu/ml
1973.2
1488.1
—
10
198
(3024522) Salmonella sp identified in Specimen by Organism specific culture
55
407
1.36
1.38
1.1
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
56
416
1.35
1.37
1.1
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
66
503
1.32
1.36
2.3
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
21
127
1.66
1.36
1.2
1.6
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
15
82
1.83
1.35
1.3
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
30
199
1.51
1.34
1.4
1.5
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
14
75
1.87
1.34
1.3
2.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
88
699
1.26
1.34
1.1
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
107
1308
0.81
1.32
1.8
2.0
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
48
350
1.38
1.32
2.3
2.0
mg/l
28.5
22.6
0.39
16
100
(3023419) Bacteria identified in Sputum by Culture
46
333
1.39
1.32
3.3
2.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
144
1.60
1.31
1.2
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
457
4161
1.11
1.31
1.4
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
27
176
1.54
1.31
1.7
1.4
nmol/l
127.2
133.3
0.28
27
176
(3017181) Myelocytes/100 leukocytes in Blood
311
2771
1.13
1.30
3.3
4.1
%
1.4
0.9
2.31
110
685
(3028717) Thiamine [Mass/volume] in Blood
9
43
2.10
1.30
1.6
1.2
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
14
76
1.84
1.29
1.1
1.1
—
76.3
—
0
13
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
14
76
1.84
1.29
1.1
1.1
—
68.6
—
0
12
(40768443) Skin Pathology biopsy report
179
1534
1.17
1.29
1.3
1.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
78
983
0.79
1.28
1.2
1.3
u/ml
59.6
44.6
—
5
108
(3002032) Base excess in Venous blood by calculation
254
2238
1.14
1.27
3.0
2.9
mmol/l
1.7
2.1
0.86
205
1794
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
77
970
0.79
1.26
1.1
1.1
u/ml
0.6
1.1
1.14
35
344
(3015171) Extractable nuclear Ab [Units/volume] in Serum
150
1765
0.84
1.25
1.2
1.3
u/ml
0.2
1.4
3.10
11
157
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
19
2.63
1.21
1.8
2.0
umol/l
33.8
42.8
—
5
19
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
14
78
1.80
1.21
1.1
1.3
%
117.9
107.5
0.78
14
72
(3017143) Hepatitis C virus Ab [Presence] in Serum
517
4760
1.10
1.20
1.5
1.5
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
21
132
1.59
1.20
1.1
1.6
%
158.3
147.9
0.21
21
118
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
21
132
1.59
1.20
1.2
1.6
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
25
164
1.53
1.20
1.4
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
68
532
1.28
1.19
1.3
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
30
205
1.47
1.19
1.4
1.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
92
1127
0.81
1.19
1.2
1.3
u/ml
2.0
9.0
—
7
184
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
41
298
1.38
1.18
1.1
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
36
256
1.41
1.17
1.2
1.2
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
33
0.00
1.16
0.0
1.2
—
5.6
—
0
10
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
33
0.00
1.16
0.0
1.1
—
18.4
—
0
33
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
33
0.00
1.16
0.0
1.1
—
5.6
—
0
7
(3027035) Albumin [Mass/time] in 24 hour Urine
0
34
0.00
1.16
0.0
1.4
—
551.4
—
0
9
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
89
723
1.24
1.15
1.2
1.2
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
5
20
2.50
1.15
2.4
1.3
pmol/l
10.4
15.9
—
5
15
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1005
9525
1.07
1.15
1.8
2.0
u/l
162.4
177.4
0.27
937
8997
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
25
368
0.68
1.15
1.0
1.1
—
39.8
—
0
5
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
247
2779
0.88
1.14
1.5
1.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
34
241
1.41
1.13
1.5
1.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
496
5370
0.91
1.12
2.0
1.9
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
56
721
0.77
1.12
3.1
3.3
mg/l
18.9
23.0
0.66
32
441
(3008757) Leukocyte morphology finding [Identifier] in Blood
40
293
1.37
1.11
3.0
3.1
—
—
—
0
0
(3000012) Reticulocyte production index
20
127
1.58
1.11
1.3
1.5
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
15
88
1.71
1.11
1.1
1.2
%
103.5
97.1
0.49
15
88
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
15
88
1.71
1.11
1.1
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
132
1120
1.18
1.11
2.5
2.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
298
2680
1.12
1.11
2.6
2.5
g/l
10.1
10.5
0.94
276
2470
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
8
41
1.95
1.08
4.6
6.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
18
112
1.61
1.08
1.8
2.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
793
8408
0.93
1.07
3.1
3.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
15
89
1.69
1.07
1.3
1.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
252
2251
1.13
1.06
3.0
2.9
kpa
5.8
5.8
0.80
240
2186
(4015189)
10
52
1.93
1.06
1.3
2.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
10
52
1.93
1.06
1.1
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
233
2072
1.13
1.05
1.7
1.8
g/l
1.2
1.4
1.62
215
1916
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
7
33
2.12
1.05
1.1
1.0
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
56
436
1.29
1.05
1.2
1.3
pmol/l
299.5
365.7
0.44
46
343
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
468
4322
1.09
1.05
1.7
1.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
35
254
1.38
1.04
1.3
1.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
39
289
1.35
1.03
1.2
1.3
—
1.5
—
0
14
(3020961) Endomysium IgA Ab [Titer] in Serum
179
2039
0.87
1.03
1.1
1.1
titre
—
232.0
—
0
57
(3019150) Specific gravity of Urine by Refractometry
824
7790
1.07
1.02
3.4
3.7
kg/l
1.0
1.0
0.75
161
1121
(3035947) Staphylolysin Ab [Units/volume] in Serum
19
122
1.56
1.02
1.1
1.1
iu/ml
—
3.4
—
0
5
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
70
864
0.81
1.01
1.3
1.3
e6/l
7.2
28.1
2.69
43
660
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
70
864
0.81
1.01
1.3
1.4
e6/l
764.6
2131.1
0.87
46
700
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
23
155
1.49
1.00
1.1
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
74
601
1.24
0.99
1.1
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
11
61
1.81
0.98
1.0
1.0
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
5
23
2.18
0.98
1.0
2.1
umol/l
438.0
218.5
—
5
23
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
22
148
1.49
0.97
1.2
1.1
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
31
0.00
0.96
0.0
1.0
—
3.4
—
0
23
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
13
77
1.69
0.95
1.0
1.2
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
13
77
1.69
0.95
1.3
1.9
e6/l
1363.6
7771.0
—
8
37
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
325
2971
1.10
0.92
1.4
1.4
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
9
52
1.73
0.92
8.2
10.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
21
142
1.48
0.92
1.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
55
437
1.26
0.91
1.4
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
985
9404
1.06
0.91
3.5
3.6
estimate
0.0
0.0
0.16
377
3202
(3045142) Bone marrow Pathology biopsy report
41
314
1.31
0.89
1.2
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
20
135
1.48
0.89
1.1
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
8
42
1.91
0.88
1.1
1.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
685
7241
0.94
0.87
1.3
1.3
u/ml
7.3
10.4
0.98
242
3006
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
23
161
1.43
0.86
1.0
1.2
g/l
0.3
0.3
1.48
17
131
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
43
334
1.29
0.86
1.1
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
279
2544
1.10
0.85
3.2
3.9
%
0.9
0.6
1.28
80
502
(3019832) Treponema pallidum Ab [Presence] in Serum
456
4887
0.93
0.85
1.7
1.6
—
—
—
0
0
(1002224) Polysomnography panel
159
1797
0.88
0.85
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
127
1104
1.15
0.84
1.6
2.0
iu/l
4.2
4.4
0.08
53
443
(3033799) Differential panel - Peritoneal fluid
13
80
1.63
0.84
1.4
1.8
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
31
1.94
0.84
1.3
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
15
96
1.56
0.84
1.3
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
175
1558
1.13
0.83
2.4
2.6
kpa
5.1
5.2
0.25
164
1447
(4024509)
24
331
0.72
0.82
1.6
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
167
1483
1.13
0.82
2.3
2.6
mmol/l
1.5
1.8
0.71
131
1108
(44816559) Phosphatidylethanol [Mass/volume] in Blood
62
753
0.82
0.81
1.2
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
73
608
1.20
0.81
1.2
1.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
130
1138
1.15
0.80
3.0
2.6
mmol/l
25.1
25.4
0.41
121
1097
(3008116) Ketones [Moles/volume] in Urine by Test strip
10
58
1.73
0.79
1.3
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
172
1536
1.12
0.78
2.4
2.6
ph
7.4
7.4
0.50
19
191
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
96
0.52
0.78
1.0
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
448
4784
0.93
0.78
1.4
1.7
%
1.3
1.4
1.09
408
4277
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
145
1635
0.88
0.77
1.4
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
26
191
1.36
0.76
1.0
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
198
1786
1.11
0.76
1.6
1.6
mu/l
300.8
298.1
0.03
182
1583
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
78
659
1.19
0.76
1.1
1.1
u/ml
269.3
257.5
0.16
47
413
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
31
235
1.32
0.75
1.8
1.8
mg/l
3.6
3.4
0.16
31
228
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
36
279
1.29
0.75
1.2
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
70
586
1.20
0.75
1.6
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
32
415
0.77
0.75
1.7
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
342
3174
1.08
0.74
16.6
14.8
inr
1.2
1.2
0.14
45
479
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
187
1686
1.11
0.74
1.5
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
374
4008
0.93
0.72
5.3
5.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
207
0.68
0.72
1.1
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
288
2657
1.09
0.72
3.3
4.1
%
0.3
0.2
0.38
98
633
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
14
92
1.52
0.72
1.1
1.0
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
23
310
0.74
0.71
1.0
1.0
u/ml
0.8
2.6
—
7
83
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
7
41
1.71
0.70
1.1
1.3
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
7
41
1.71
0.70
1.1
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
7
41
1.71
0.70
6.1
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
240
2203
1.09
0.68
3.0
2.4
g/l
66.0
67.2
1.63
222
2019
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
192
0.68
0.68
1.2
1.1
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
21
153
1.37
0.67
1.3
1.6
—
689097.8
—
0
9
(3008898) HLA-B27 [Presence]
158
1753
0.90
0.66
1.1
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
295
2737
1.08
0.66
1.3
1.3
u/ml
160.3
179.2
0.26
270
2546
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
95
0.53
0.66
1.0
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
544
5732
0.94
0.66
1.4
1.4
titre
545.8
568.4
0.09
104
1177
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
982
9464
1.05
0.65
1.3
1.3
u/ml
0.9
1.6
3.07
207
2696
(3003338) MCHC [Mass/volume]
3361
33982
0.96
0.65
20.7
13.8
g/l
332.0
332.0
0.11
3344
33765
(3024471) HLA-A [Type]
7
44
1.59
0.65
1.0
1.0
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
35
277
1.27
0.65
1.2
1.1
iu/ml
17.2
9.0
0.50
11
79
(3030981) Hyaline casts [#/volume] in Urine by Automated count
164
1482
1.11
0.64
2.6
2.3
e6/l
0.2
0.2
0.04
157
1411
(3026493) Urate [Moles/volume] in Serum or Plasma
888
8543
1.05
0.64
2.3
2.1
umol/l
2128.6
3938.9
1.16
782
7513
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
26
198
1.31
0.64
1.0
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
130
0.61
0.63
1.5
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
84
966
0.87
0.63
1.5
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
70
599
1.17
0.62
1.6
2.1
g/l
132.2
130.0
0.36
53
425
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
34
270
1.26
0.62
1.7
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
124
1106
1.12
0.62
1.2
1.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
94
1069
0.88
0.61
2.9
2.0
g/l
7.2
7.4
0.37
71
823
(3004119) Hemoglobin [Mass/volume] in Venous blood
166
1508
1.10
0.60
2.8
2.5
g/l
129.8
131.8
0.54
157
1473
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
104
1174
0.88
0.60
2.3
2.4
%
1.1
1.3
0.90
104
1165
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
94
1068
0.88
0.60
2.9
2.0
g/l
3.6
3.8
0.80
68
781
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
94
1068
0.88
0.60
2.9
2.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
13
88
1.48
0.60
1.2
1.1
—
—
—
0
0
(3037297) Penicillin G IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
0.1
—
0
8
(3029396) Erythrocyte agglutination [Presence] in Blood
19
139
1.37
0.60
3.6
3.3
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.2
—
37.7
—
0
16
(3043238) Trisomy 21 risk [Likelihood] in Fetus
116
1299
0.89
0.59
1.4
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
32
400
0.80
0.59
1.1
1.1
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
22
0.00
0.59
0.0
1.7
—
335.3
—
0
22
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
52
617
0.84
0.58
1.5
1.7
nmol/l
0.8
0.8
0.05
46
532
(3044941) Cell count panel - Synovial fluid
60
510
1.18
0.58
1.4
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
773
8037
0.95
0.58
1.4
1.4
g/l
2.1
2.2
1.19
472
5025
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
113
0.62
0.58
1.7
1.6
ug/l
7.0
8.6
—
7
113
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
8
54
1.48
0.57
1.1
1.4
ng/l
82.3
99.8
—
8
54
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
20
264
0.76
0.57
1.0
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
12
81
1.48
0.57
1.1
1.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
66
568
1.16
0.56
1.2
1.3
—
237.1
—
0
14
(3047352) Trisomy 18 risk [Likelihood] in Fetus
113
1261
0.89
0.56
1.4
1.4
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
49
581
0.84
0.56
1.0
1.0
u/ml
0.1
0.5
—
9
115
(40768446) Kidney Pathology biopsy report
10
65
1.54
0.55
1.8
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
65
1.54
0.55
2.2
1.6
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
35
284
1.23
0.55
1.1
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
927
8967
1.04
0.54
1.6
1.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
271
2533
1.07
0.54
3.4
4.2
%
0.1
0.2
0.10
81
544
(3005033) Fetal Nuchal fold Thickness US
113
1257
0.90
0.53
1.4
1.4
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
9
61
1.48
0.53
1.4
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
139
1528
0.91
0.53
1.4
1.4
—
—
—
0
0
(3000492) Spirometry study
359
3799
0.94
0.53
1.4
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
15
108
1.39
0.53
1.1
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
15
108
1.39
0.53
1.1
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
87
982
0.88
0.53
1.2
1.3
mg/l
499.4
502.6
0.02
81
936
(3014765) Yersinia sp identified in Stool by Organism specific culture
124
1120
1.11
0.53
1.2
1.1
—
—
—
0
0
(44813793)
26
327
0.79
0.52
1.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
139
1527
0.91
0.52
1.4
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
35
286
1.23
0.52
1.1
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
12
83
1.45
0.51
1.3
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
6
40
1.50
0.51
1.0
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
139
1524
0.91
0.51
1.4
1.4
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
9
65
1.39
0.50
1.0
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
62
712
0.87
0.49
1.1
1.1
u/ml
1.2
3.8
2.50
21
256
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
139
1520
0.91
0.49
1.4
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
7
45
1.56
0.49
1.1
1.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
47
400
1.18
0.48
1.6
1.8
pmol/l
177.6
188.8
0.25
47
367
(3003740) Influenza virus B Ag [Presence] in Specimen
86
766
1.13
0.48
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
124
1128
1.10
0.47
1.2
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
55
635
0.86
0.47
1.2
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
70
794
0.88
0.47
1.1
1.1
u/ml
2.3
2.1
0.04
14
187
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
51
438
1.17
0.47
1.2
1.3
—
32.6
—
0
5
(4027681)
33
273
1.21
0.46
1.3
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
189
1757
1.08
0.45
1.5
1.5
mg/l
2.1
3.4
2.54
129
1217
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
76
854
0.89
0.45
2.7
2.0
g/l
38.9
38.6
0.24
65
748
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
510
4892
1.05
0.45
1.7
1.8
—
—
—
0
0
(4211845)
23
183
1.26
0.44
3.7
2.8
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
26
319
0.81
0.44
1.0
1.0
u/ml
0.4
0.9
—
8
68
(3020191) Ethanol [Moles/volume] in Serum or Plasma
29
238
1.22
0.44
1.0
1.6
promille
1.1
1.3
0.35
24
183
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
89
988
0.90
0.43
2.7
2.1
g/l
9.6
10.2
0.77
74
850
(3026470) Cobalt [Mass/volume] in Blood
9
128
0.70
0.43
2.0
2.0
ug/l
3.7
3.1
—
9
114
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
9
129
0.70
0.43
1.0
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
77
861
0.89
0.43
1.2
1.2
mmol/l
3.5
3.7
0.61
72
807
(3022621) pH of Urine by Test strip
250
2355
1.07
0.43
2.7
2.7
—
—
—
0
0
(4094501)
101
916
1.10
0.43
1.0
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
77
688
1.12
0.42
1.1
1.1
au/ml
3.7
11.6
—
7
38
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
54
617
0.87
0.42
1.6
1.6
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
16
122
1.31
0.42
1.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
32
1.56
0.42
1.4
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
32
1.56
0.42
1.2
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
92
1016
0.90
0.42
2.9
2.1
g/l
3.1
3.1
0.00
72
804
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
36
424
0.85
0.41
1.0
1.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
75
837
0.89
0.41
3.1
2.0
g/l
0.0
0.0
0.12
68
773
(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
0.1
—
0
6
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
41
477
0.86
0.41
1.4
1.3
—
—
—
0
0
(3007456) Orange IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
0.2
—
0
9
(3002523) Influenza virus A Ag [Presence] in Specimen
85
766
1.11
0.41
1.0
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
145
1342
1.08
0.41
1.6
2.2
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.4
—
423.4
—
0
17
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
15
114
1.32
0.40
2.5
2.4
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
5
34
1.47
0.40
1.0
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
36
306
1.18
0.39
3.7
3.2
nmol/l
0.7
0.8
1.13
31
230
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
734
7563
0.96
0.39
1.3
1.3
iu/ml
27.5
30.4
0.22
232
2407
(3000034) Microalbumin [Mass/volume] in Urine
22
270
0.81
0.39
2.5
2.8
mg/l
104.7
23.1
0.73
17
188
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
19
0.00
0.39
0.0
1.6
—
0.0
—
0
6
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
84
927
0.90
0.38
3.3
2.1
g/l
1.1
0.7
0.42
72
817
(3027923) C peptide [Moles/volume] in Serum or Plasma
20
160
1.25
0.38
1.6
1.6
nmol/l
1.1
1.4
1.05
15
131
(3005011) Chlamydia sp Ab [Titer] in Serum
9
66
1.36
0.38
1.4
1.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
112
1029
1.09
0.38
1.2
1.2
titre
60.0
145.8
—
8
93
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
37
430
0.86
0.37
1.5
1.5
—
1930.0
—
0
8
(3044927) Protein electrophoresis panel - Urine
29
243
1.19
0.37
1.3
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
13
98
1.33
0.37
1.2
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
13
98
1.33
0.37
1.4
1.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
12
158
0.76
0.37
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
220
2328
0.94
0.37
1.3
1.4
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
17
134
1.27
0.36
1.3
1.4
pmol/l
50.7
58.8
—
6
41
(3024928) Oxygen saturation in Venous blood
58
516
1.13
0.36
1.7
2.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
55
488
1.13
0.36
2.4
1.5
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
12
90
1.33
0.35
1.0
1.9
ug/l
1.9
2.1
—
7
47
(3024932) HLA-DR beta [Type]
6
42
1.43
0.35
1.3
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
134
1246
1.08
0.35
1.3
1.4
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
5
80
0.62
0.35
1.2
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
18
144
1.25
0.35
1.1
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
9
122
0.74
0.35
1.0
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
128
1190
1.08
0.34
2.9
3.0
mmol/l
24.2
24.5
0.35
117
1059
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
23
275
0.84
0.33
1.1
1.2
—
68.0
—
0
5
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
6
46
1.30
0.33
1.0
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
6
88
0.68
0.33
1.3
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
89
0.67
0.33
1.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
6
89
0.67
0.33
1.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
68
749
0.91
0.32
1.8
2.9
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
6
47
1.28
0.32
1.0
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
11
143
0.77
0.32
1.0
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
158
1678
0.94
0.31
1.2
1.3
miu/ml
247.1
229.8
0.24
69
866
(3006922) Hepatitis E virus Ab [Presence] in Serum
30
258
1.16
0.31
1.1
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
96
0.73
0.30
1.0
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
872
8916
0.97
0.30
3.8
3.7
mg/mmol
7.0
7.7
0.22
461
5376
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
71
777
0.91
0.30
2.8
2.1
g/l
0.0
0.0
0.49
64
716
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
7
54
1.30
0.30
7.1
6.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
7
54
1.30
0.30
3.6
3.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
47
419
1.12
0.30
1.6
1.6
mmol/l
7.1
7.7
1.10
28
258
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
82
754
1.09
0.30
3.9
3.3
mg/l
26.0
34.0
1.24
63
627
(3034860) Kappa light chains.free [Mass/volume] in Serum
82
754
1.09
0.30
3.9
3.3
mg/l
53.5
119.7
0.42
63
622
(3006462) Nitrate [Presence] in Urine
20
166
1.21
0.29
4.0
2.9
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
350
3372
1.04
0.29
1.2
1.2
iu/ml
137.7
162.3
0.65
145
1333
(3012494) Peanut IgE Ab [Units/volume] in Serum
10
130
0.77
0.29
1.1
1.1
u/ml
0.3
2.2
—
5
64
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
26
222
1.17
0.29
1.0
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
21
176
1.19
0.28
1.6
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3612
36303
0.97
0.28
4.0
4.0
mmol/l
5.7
5.7
2.87
3343
33744
(3004588) Protein electrophoresis panel - Serum or Plasma
170
1793
0.95
0.28
2.6
2.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
31
270
1.15
0.28
2.9
2.6
%
52.7
55.9
0.45
23
175
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
34
386
0.88
0.28
1.5
1.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
279
2903
0.96
0.27
2.4
2.4
au/ml
17.4
24.4
0.88
20
216
(3016018) Differential panel - Cerebral spinal fluid
47
423
1.11
0.27
1.4
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
59
538
1.10
0.26
3.9
3.5
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
13
104
1.25
0.26
1.2
1.4
umol/l
16.2
17.7
0.88
13
91
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
71
770
0.92
0.26
2.8
2.1
g/l
0.0
0.0
0.00
64
714
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
72
0.69
0.26
1.4
1.1
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
39
348
1.12
0.26
1.0
1.1
mg/l
319.8
234.5
0.59
34
307
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
30
341
0.88
0.25
1.5
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3334
33520
0.98
0.25
4.6
4.7
mmol/mol
38.1
38.4
1.36
3113
31438
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
9
75
1.20
0.25
1.1
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
109
1159
0.94
0.25
1.7
1.7
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
9
76
1.18
0.24
1.0
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
12
96
1.25
0.24
1.2
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
34
302
1.13
0.24
1.7
1.2
u/ml
4.3
1.1
0.62
15
123
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
15
124
1.21
0.24
1.1
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
25
286
0.87
0.23
2.0
1.4
e6/l
18506.4
21540.7
0.06
15
187
(40757494) Bilirubin.total [Moles/volume] in Blood
13
158
0.82
0.23
2.9
2.3
—
24.4
—
0
15
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
52
568
0.91
0.23
1.3
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1478
14965
0.98
0.23
2.5
2.4
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
25
285
0.88
0.23
1.3
1.2
—
67.6
—
0
13
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
40
1.25
0.22
6.0
6.0
—
—
—
0
0
(4133840)
7
95
0.74
0.22
1.0
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
168
1607
1.05
0.22
1.5
2.1
—
—
—
0
0
(4198724)
15
178
0.84
0.22
1.1
2.9
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
1.9
—
0
10
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(4062490)
42
382
1.10
0.21
1.2
1.4
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
2.4
—
0
12
(3020911) Cortisol [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.3
—
109.8
—
0
12
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
15.6
—
0
7
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
27
239
1.13
0.21
1.7
1.8
—
—
—
0
0
(3013762) Body weight Measured
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
13
0.00
0.21
0.0
2.5
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
11
89
1.24
0.21
1.3
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
42
460
0.91
0.20
1.0
1.1
—
3.9
—
0
6
(3023183) Ammonium ion [Moles/volume] in Plasma
55
508
1.08
0.20
1.8
2.5
umol/l
28.0
34.2
1.62
47
442
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
24
272
0.88
0.20
1.3
1.5
%
34.5
35.8
0.06
12
159
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
39
354
1.10
0.20
1.2
1.4
mmol/l
10.3
12.9
—
8
63
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
72
673
1.07
0.20
1.1
1.1
u/ml
1.5
3.6
2.51
38
343
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
40
364
1.10
0.20
2.6
2.4
—
—
—
0
0
(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
0.1
—
0
5
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
6
49
1.22
0.20
1.0
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
61
655
0.93
0.20
1.9
2.1
umol/l
5.4
5.1
0.10
42
472
(3030313) Adrenal Ab [Titer] in Serum
6
50
1.20
0.19
1.0
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
51
1.18
0.19
1.2
1.5
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
6
52
1.15
0.19
1.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
6
53
1.13
0.18
1.5
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
53
1.13
0.18
2.3
1.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
19
217
0.88
0.18
1.1
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
859
8464
1.02
0.18
1.9
1.8
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
42
386
1.09
0.18
1.2
1.4
g/l
6.7
6.6
0.05
27
276
(3028192) IgG subclass 2 [Mass/volume] in Serum
42
386
1.09
0.18
1.2
1.4
g/l
2.4
2.9
1.44
27
275
(3024139) IgG subclass 3 [Mass/volume] in Serum
42
386
1.09
0.18
1.2
1.4
g/l
0.3
0.4
2.13
26
276
(3017817) Protein [Mass] in Urine collected for unspecified duration
20
227
0.88
0.18
2.0
2.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
508
4981
1.02
0.17
1.4
1.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
190
1836
1.04
0.17
2.6
2.5
kpa
4.9
4.6
0.99
182
1780
(3048879) Bone marrow aspiration report
7
62
1.13
0.17
1.7
1.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
114
1192
0.96
0.17
1.4
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
30
272
1.10
0.17
2.4
1.6
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
17
148
1.15
0.16
1.1
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
53
567
0.93
0.16
1.6
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
12
101
1.19
0.16
2.9
2.5
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
55
587
0.94
0.16
3.1
2.6
mmol/l
24.5
25.2
0.78
46
509
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
159
1534
1.04
0.16
2.2
1.9
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
39
360
1.08
0.16
1.1
1.1
mg/l
46.4
37.2
0.41
31
308
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
6
76
0.79
0.15
1.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
6
76
0.79
0.15
1.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
6
76
0.79
0.15
1.0
1.0
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
17
149
1.14
0.15
1.4
1.4
%
76.6
72.2
1.06
17
142
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
6
80
0.75
0.15
1.2
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
12
140
0.86
0.15
1.6
1.8
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
9
81
1.11
0.15
1.1
1.3
mu/l
63.2
53.3
—
9
62
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
127
1319
0.96
0.15
1.4
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
69
654
1.06
0.14
1.2
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
192
1864
1.03
0.14
1.5
1.4
—
—
—
0
0
(4010399)
255
2487
1.03
0.14
1.3
1.4
—
—
—
0
0
(3020891) Body temperature
107
1027
1.04
0.14
3.9
4.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
10
84
1.19
0.14
1.4
1.5
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
26
237
1.10
0.14
1.5
2.1
u/field
2.6
2.2
0.13
15
112
(43055514) Macroprolactin [Presence] in Serum or Plasma
14
122
1.15
0.13
1.1
1.5
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
21
189
1.11
0.13
2.2
2.8
%
44.1
43.3
0.07
15
64
(3048689) Calprotectin [Mass/mass] in Stool
533
5248
1.02
0.13
1.9
2.3
ug/g
102.1
111.2
0.32
426
4155
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
111
1153
0.96
0.13
1.1
1.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
60
633
0.95
0.13
1.4
1.4
mmol/l
7.0
7.1
0.13
46
467
(3023430) Cat dander IgE Ab [Units/volume] in Serum
62
653
0.95
0.13
1.1
1.1
u/ml
0.9
3.6
4.22
27
243
(3017569) Oxygen content in Arterial blood
9
106
0.85
0.13
2.3
2.9
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
42
448
0.94
0.13
1.0
1.1
—
102.2
—
0
6
(3011648) Oxygen content in Venous blood
23
209
1.10
0.13
1.4
1.7
%
12.5
11.1
0.64
23
209
(3004451) EKG impression Narrative
12
104
1.15
0.12
1.3
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
371
3775
0.98
0.12
1.9
1.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
318
3120
1.02
0.12
1.4
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
37
395
0.94
0.12
2.0
2.4
—
—
—
0
0
(4146454)
31
288
1.08
0.11
2.6
2.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
35
327
1.07
0.11
1.4
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
197
1924
1.03
0.11
1.5
2.0
ug/l
4.6
5.3
0.36
166
1690
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
33
353
0.93
0.11
1.1
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
25
270
0.93
0.10
3.5
5.4
mmol/l
7.1
7.1
0.02
18
224
(3047007) Chlamydophila sp Ab [Presence] in Serum
68
652
1.04
0.10
1.4
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
33
352
0.94
0.10
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
33
352
0.94
0.10
1.1
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
170
1660
1.03
0.10
1.7
1.7
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
11
125
0.88
0.10
1.4
1.5
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
5
44
1.14
0.10
1.0
1.1
—
48.3
—
0
18
(3033705) Calcium.ionized [Moles/volume] in Venous blood
25
269
0.93
0.10
2.6
2.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
12
106
1.13
0.09
4.2
1.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
31
291
1.07
0.09
1.5
1.7
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
5
48
1.04
0.09
1.2
1.2
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
16
145
1.10
0.09
1.4
1.4
mu/l
2579.4
414.7
0.55
16
138
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
33
350
0.94
0.09
1.1
1.2
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
45
472
0.95
0.09
1.7
1.6
—
3.3
—
0
8
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
25
233
1.07
0.09
2.2
2.4
e6/l
734.8
791.5
0.16
12
95
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
117
1201
0.97
0.09
1.6
1.8
g/l
0.2
0.2
0.09
111
1131
(3001893) Eosinophils/100 leukocytes in Pleural fluid
6
56
1.07
0.08
1.2
1.6
%
2.2
4.7
—
6
50
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
33
349
0.95
0.08
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
33
349
0.95
0.08
1.1
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
57
548
1.04
0.08
1.5
1.6
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
41
430
0.95
0.08
1.1
1.3
u/l
31.2
27.5
0.10
31
375
(3027008) Opiates [Presence] in Urine
180
1766
1.02
0.08
1.5
1.9
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
63
653
0.96
0.08
3.9
3.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
84
815
1.03
0.08
1.5
1.6
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
263
2669
0.98
0.08
1.2
1.3
au/ml
35.3
44.9
—
10
124
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
131
1281
1.02
0.08
1.3
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
25
266
0.94
0.07
3.8
4.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
178
1748
1.02
0.07
1.6
2.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
15
137
1.10
0.07
1.1
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
8
75
1.07
0.07
1.3
2.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
77
1.04
0.07
1.1
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
78
758
1.03
0.07
1.8
1.7
e6/l
26455.6
9151.4
0.72
56
530
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
9
84
1.07
0.07
2.3
2.0
umol/l
15.3
16.8
—
9
84
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
19
204
0.93
0.07
1.1
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
8
94
0.85
0.06
1.1
8.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
180
1771
1.02
0.06
1.7
2.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
709
7044
1.01
0.06
1.6
1.6
—
—
—
0
0
(3024263) Appearance of Synovial fluid
15
162
0.93
0.06
1.3
1.9
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
23
217
1.06
0.06
1.2
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
83
850
0.98
0.06
1.9
1.9
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
31
324
0.96
0.05
1.2
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
178
1755
1.01
0.05
1.5
2.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
87
851
1.02
0.05
1.2
1.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
14
151
0.93
0.05
1.1
2.0
umol/l
80.6
171.5
—
8
82
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
16
171
0.94
0.05
1.1
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
80
817
0.98
0.04
1.6
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
163
1612
1.01
0.03
1.6
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
154
1557
0.99
0.03
2.9
2.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
82
807
1.02
0.03
1.3
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
953
9558
1.00
0.03
2.9
3.0
mmol/l
7.4
7.5
0.32
808
8105
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
118
0.93
0.02
1.1
1.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
13
138
0.94
0.02
1.5
1.9
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
16
152
1.05
0.02
1.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
119
1180
1.01
0.01
2.0
3.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
293
2940
1.00
0.01
1.8
1.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
56
567
0.99
0.01
1.5
1.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
29
284
1.02
0.00
2.1
2.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
851
8503
1.00
0.00
3.1
3.1
mg/l
824.6
391.2
0.99
452
5069
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
232
2326
1.00
0.00
1.1
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
11
112
0.98
0.00
1.2
1.1
u/ml
43.5
52.5
0.17
11
106
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
12
122
0.98
0.00
1.2
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
12
122
0.98
0.00
1.2
1.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
20
198
1.01
0.00
1.1
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
26
262
0.99
0.00
1.0
1.1
u/l
1.2
1.1
0.08
14
117
(3044242) Glucose [Moles/volume] in Arterial blood
13
125
1.04
0.00
1.5
2.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
24
245
0.98
0.00
1.5
1.5
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
60
598
1.00
0.00
1.3
1.6
g/l
0.5
0.7
2.18
41
462
(3025130) Human papilloma virus identified in Specimen
85
848
1.00
0.00
1.8
1.8
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
123
1232
1.00
0.00
1.5
1.8
g/l
1.2
1.2
0.11
116
1165
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
74
745
0.99
0.00
2.0
1.7
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
13
126
1.03
0.00
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
24
237
1.01
0.00
1.1
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
34
337
1.01
0.00
1.0
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
11
109
1.01
0.00
1.4
2.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
22
219
1.00
0.00
1.0
3.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
24
239
1.00
0.00
1.1
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
26
259
1.00
0.00
1.7
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
31
309
1.00
0.00
1.4
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
77
771
1.00
0.00
1.1
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
9
89
1.01
0.00
2.3
2.4
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
6
66
0.91
0.00
1.2
1.5
%
66.7
64.5
—
6
57
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
5
0.00
0.00
0.0
1.4
—
7.5
—
0
5
(3040794) Aluminum [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
1.3
—
0
6
(3000919) Neutrophils/100 leukocytes in Pleural fluid
5
56
0.89
0.00
1.2
1.5
%
21.1
20.4
—
5
51
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
0
9
0.00
0.00
0.0
3.7
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
7
75
0.93
0.00
1.0
1.1
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
7
0.00
0.00
0.0
7.4
—
—
—
0
0
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
5
0.00
0.00
0.0
1.4
—
33.0
—
0
5
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
6
62
0.97
0.00
1.2
1.5
g/l
22.8
13.9
—
6
46
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
49
1.02
0.00
1.2
1.0
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
58
0.86
0.00
1.0
1.3
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
92
0.98
0.00
4.3
4.6
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
5
0.00
0.00
0.0
1.4
—
2.5
—
0
5
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
23
230
1.00
0.00
2.8
2.1
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
77
0.91
0.00
1.6
4.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
77
0.91
0.00
1.6
4.2
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
1.1
—
0
7
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
7
73
0.96
0.00
1.4
1.2
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.2
—
343.6
—
0
5
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
9
92
0.98
0.00
2.3
1.4
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.2
—
17.6
—
0
5
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
78
0.90
0.00
1.0
1.1
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
43.4
—
0
5
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
1226.7
—
0
6
(3036525) Urea [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
6
65
0.92
0.00
1.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_FAMILY_HISTORY_MALIG_NEOPLASM – Family history of malignant neoplasm
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).